Hariprasad CV 7-2015 - APAO 20162016.apaophth.org/.../2015/07/Hariprasad-CV-7-2015.pdf ·...

CURRICULUM VITAE

NAME: Seenu Mavidi Hariprasad ADDRESS: The University of Chicago Department of Ophthalmology and Visual Science 5841 S. Maryland Ave. MC 2114 Chicago, IL 60637 Telephone: 773-795-1326 Fax: 773-702-6615 E-mail: [email protected] Webpage: http://www.uchospitals.edu/physicians/seenu-hariprasad.html DATE OF BIRTH: May 9, 1973 CITIZENSHIP: United States of America MARITAL STATUS: Married with two children EDUCATION: Cornell University, College of Arts & Sciences, Ithaca, NY, 1991-1994 Bachelor of Arts with Distinction in all Subjects Major: Neurobiology & Behavior University of Pennsylvania School of Medicine, Philadelphia, PA, 1995-1999 Doctorate of Medicine Member Alpha Omega Alpha (AΩA) GRADUATE TRAINING: Transitional Internship, Baylor College of Medicine- Affiliated Hospitals Residency Program, Houston, TX, 1999-2000 Ophthalmology Residency, Cullen Eye Institute- Baylor College of Medicine, Houston, TX, 2000-2003 Fellowship in the Diseases and Surgery of the Retina, Vitreous, and Macula, Barnes Retina Institute- Washington University School of Medicine, St. Louis, MO, 2003-2005 FACULTY APPOINTMENT:

Shui-Chin Lee Professor of Ophthalmology and Visual Science, Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, IL, 2015-present. Professor, Department of Surgery, Section of Ophthalmology and Visual Science, The University of Chicago, Chicago, IL, 2014-2015. Associate Professor, Department of Surgery, Section of Ophthalmology and Visual Science, The University of Chicago, Chicago, IL, 2009-2014.

Seenu M. Hariprasad

2

Assistant Professor, Department of Ophthalmology and Visual Science, The University of

Chicago, Chicago, IL, 2005-2008. Director, Clinical Research, Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, IL, 2005-present. Chief, Vitreoretinal Service, Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, IL, 2007-present.

Program Director, Fellowship in the Diseases and Surgery of the Retina, Vitreous, and Macula, Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, IL, 2008-present.

Chief, Vitreoretinal Service, Weiss Memorial Hospital, 2008-2012. HOSPITAL APPOINTMENT: Attending Staff, The University of Chicago Medicine, Chicago, IL, 2005-present. Attending Staff, Illinois Eye Institute, Chicago, IL, 2005-present. Attending Staff, Illinois Masonic Hospital, Chicago, IL, 2006-2008. Attending Staff, Weiss Memorial Hospital, Chicago, IL, 2007-2012. CERTIFICATION AND LICENSURE: Diplomate of the American Board of Ophthalmology: Written (2004), Oral (2004), Recertification (2012) USMLE: I (1997), II (1999), III (2000) Missouri Medical License Number: 2003004985 (2003-2005) Illinois Medical License Number: 036-113133 (2005-present) HONORS AND AWARDS: Bausch & Lomb and Alfred University Scholar for excellence in Science and Math Cornell University Dean's List Phi Kappa Phi (ΦΚΦ), Phi Beta Kappa (ΦΒΚ), and Golden Key National Honor Society American Association of Physicians of Indian Origin Award for Excellence in Clinical Research NIH Student Research Fellowship (University of Pennsylvania School of Medicine), 1995 Beta Chapter Medical School Honor Society Alpha Omega Alpha (AΩA) Recipient of the Everett L. Goar Award for Best Resident Research (Cullen Eye Institute), 2002 Recipient of The Retina Society Research/Travel Award (36th Scientific Session), 2003 National Eye Institute Travel Grant Recipient (ARVO), 2004 American Ophthalmological Society Travel Grant Recipient (140th Scientific Session), 2004 Annenberg Center for Health Sciences Scholarship Recipient, 2005 American Ophthalmological Society Travel Grant Recipient (142nd Scientific Session), 2006 Guide to America’s Top Ophthalmologists, Consumers’ Research Council of America, 2007-present American Academy of Ophthalmology Achievement Award, 2010 American Society of Retina Specialists Honor Achievement Award, 2010 Patients’ Choice Award- Ophthalmology, 2010-present Chicago Top Doctors Award, 2011-present 135 Leading Ophthalmologists in America, Becker’s ASC Review, 2011 Castle Connolly America’s Top Doctors, 2011-present

Seenu M. Hariprasad

3

US News & World Report Top Doctor Award, 2011-present Who’s Who in America, 2012-present University of Chicago Ophthalmology Resident’s Excellence in Teaching Award, 2012 The Leading Physicians of the World- International Association of Ophthalmologists, 2014 Chicago Magazine Biennial List of Outstanding Doctors, 2014 MEMBERSHIPS IN PROFESSIONAL SOCIETIES: The Macula Society The Retina Society American Society of Retina Specialists (ASRS) Club Vit American Academy of Ophthalmology (AAO) The Association for Research in Vision and Ophthalmology (ARVO) American Society of Cataract and Refractive Surgeons (ASCRS) Chicago Ophthalmological Society (COS) Chicago Medical Society European Society of Retina Specialists (EURETINA) American College of Physicians (ACP) American Medical Association (AMA) Texas Ophthalmological Association (TOA), 1999-2003 Missouri Society of Eye Physicians and Surgeons (MOSEPS), 2003-2005 COMMITTEE AND BOARD APPOINTMENT: University of Chicago Institutional Review Board Member, 2006-2009 University of Chicago Department of Surgery Clinical Trials Advisory Panel, 2010-present American Academy of Ophthalmology, Representative from the Macula Society to develop the Retina/Vitreous Section of the Practicing Ophthalmologists Curriculum (POC), 2012 University of Chicago Biological Sciences Division Committee on Reappointment of Assistant Professors (COROAP), 2012-2013 American Society of Retina Specialists, Corporate Relations Committee, 2012-2013 American Society of Retina Specialists, Fellowship Directors’ Standards Committee, 2014-present University of Chicago Biological Sciences Division Committee on Appointments and Promotions (COAP), 2015-present BIBLIOGRAPHY: Peer Reviewed Articles:

1. Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, Maguire AM, Ho AC: Foveolar Choroidal Blood Flow in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 39(2): 385-390, 1998.

2. Grunwald JE, Hariprasad SM, DuPont J: Effect of Aging on the Foveolar Choroidal

Circulation. Arch Ophthalmol 116(2): 150-154, 1998.

3. Grunwald JE, Piltz J, Hariprasad SM, DuPont J: Optic Nerve and Choroidal Circulation in Glaucoma. Invest Ophthalmol Vis Sci 39(12): 2329-2336, 1998.

Seenu M. Hariprasad

4

4. Grunwald JE, Piltz JR, Hariprasad SM, DuPont J, Maguire MG: Optic Nerve Blood Flow in Glaucoma: Effect of Systemic Hypertension. Am J Ophthalmol 127(5): 516-522, 1999.

5. Piltz JR, Grunwald JE, Hariprasad SM, DuPont J: Optic Nerve Blood Flow is

Diminished in Eyes of Primary Open-angle Glaucoma Suspects. Am J Ophthalmol 132 (1): 63-69, 2001.

6. Hariprasad SM, Mieler WF, Holz ER: Vitreous Penetration of Orally Administered

Gatifloxacin in Humans. Tr Am Ophth Soc 100: 153-159, 2002.

7. Hariprasad SM, Moon SJ, Allen RC, Wilhelmus KR: Keratopathy from Congenital Syphilis. Cornea 21(6): 608-60, 2002.

8. Hua G, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER:

Safety of Intravitreal Voriconazole- Electroretinographic and Histopathologic Studies. Tr Am Ophth Soc 101: 183-189, 2003.

9. Hariprasad SM, Mieler WF, Holz ER: Vitreous and Aqueous Penetration of Orally

Administered Gatifloxacin in Humans. Arch Ophthalmol. 121(3): 345-350, 2003.

10. Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, Prince RA: Determination of Vitreous, Aqueous, and Plasma Concentration of Orally Administered Voriconazole in Humans. Arch Ophthalmol 122 (1): 42-47, 2004.

11. Gao H, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER:

Intravitreal Voriconazole- An Electroretinographic and Histopathologic Study. Arch Ophthalmol 122 (11): 1687-1692, 2004. Erratum in: Arch Ophthalmol 123(1): 130, 2005.

12. Hariprasad SM, Mieler WF, Shah GK, Blinder KJ, Apte RS, Holekamp NM, Thomas

MA, Chi J, Prince RA: Human Intraocular Penetration Pharmacokinetics of Moxifloxacin 0.5% via Topical and Collagen Shield Routes of Administration. Tr Am Ophth Soc 102: 149-157, 2004.

13. Shah GK, Blinder K, Hariprasad SM, Thomas MA, Ryan EH, Bakal J, Sharma S:

Photodynamic Therapy for Juxtafoveal Choroidal Neovascularization Due to Ocular Histoplasmosis Syndrome. Retina 25(1): 26-32, 2005.

14. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills M, Grand MG: Management

of Endogenous Fungal Endophthalmitis with Voriconazole and Caspofungin. Am J Ophthalmol 139(1): 135-140, 2005.

15. Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Thomas MA, Holekamp

NM, Mieler WF, Chi J, Prince RA: Penetration Pharmacokinetics of Topically Administered 0.5% Moxifloxacin Ophthalmic Solution in Human Aqueous and Vitreous. Arch Ophthalmol 123(1): 39-44, 2005.

16. Hariprasad SM, Prasad A, Smith M, Shah GK, Grand MG, Shepherd JB, Wickens J,

Apte RS, Liao R, VanGelder R: Bilateral Choroiditis from Prototheca Wickerhamii Algaemia. Arch Ophthalmol 123(8): 1138-1141, 2005.

Seenu M. Hariprasad

5

17. Ebenezer ND, Patel CB, Hariprasad SM, Chen LL, Patel RJ, Hardcastle AJ, Webster AR, Allen RC: Clinical and Molecular Characterization of a Family with Autosomal Recessive Cornea Plana (CNA2). Arch Ophthalmol 123(9): 1248-53, 2005.

18. Hariprasad SM, Shah GK: Treatment of Juxtafoveal Choroidal Neovascularization with Photodynamic Therapy using Verteporfin in Eyes with Age-Related Macular Degeneration. Ophthalmic Surg Lasers Imaging 36(3): 258-260, 2005.

19. Hariprasad SM, Shah GK, Chi J, Prince RA: Determination of Aqueous and Vitreous Concentration of Moxifloxacin 0.5% in Humans After Delivery via a Dissolvable Corneal Collagen Shield Device. J Cataract and Refractive Surg 31(11): 2142-2146, 2005.

20. Hariprasad SM, Shah GK, Blinder KJ: Short-Term Intraocular Pressure Trends Following Intravitreal Pegaptanib (Macugen) Injection. Am J Ophthalmol 141(1): 200-201, 2006.

21. Hariprasad SM, Shah GK, Mieler WF, Feiner L, Blinder KJ, Holekamp NM, Gao H, Prince RA: Vitreous and Aqueous Penetration of Orally Administered Moxifloxacin in Humans. Arch Ophthalmol 124(2): 178-182, 2006. 22. Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS: Retinal Pigment Epithelial Tear Following Intravitreal Pegaptanib Sodium. Am J Ophthalmol 141(4): 752-754,

2006.

23. Alexandrou TJ, Hariprasad SM, Benevento J, Rubin MP, Saidel M, Ksiazek S, Thompson K, Boonlayangoor S, Mieler WF: Reduction of Preoperative Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment. Trans Am Ophth Soc 104: 196-201, 2006.

24. Lee EW, Hariprasad SM, Mieler WF, Newman TL, Apte RS: Short-term Intraocular

Pressure Trends After Intravitreal Triamcinolone Injection. Am J Ophthalmology 143 (2): 365-367, 2007.

25. Hariprasad SM, Callanan D, Gainey S, He YG, Warren K: Cystoid and Diabetic Macular

Edema Treated with Nepafenac 0.1%. J Ocul Pharmacol Ther 23(6): 585-590, 2007. 26. Vemulakonda GA, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN:

Aqueous and Vitreous Concentrations Following Topical Administration of 1% Voriconazole in Humans. Arch Ophthalmol 126(1): 18-22, 2008.

27. Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L: Vision-Related

Quality of Life in Patients with Diabetic Macular Oedema. Br J Ophthalmol 92(1): 89-92, 2008.

28. Lin RC, Sanduja N, Hariprasad SM: Successful Treatment of Postoperative Fungal

Endophthalmitis Using Intravitreal and Intracameral Voriconazole. J Ocul Pharmacol Ther 24(2): 245-248, 2008.

29. Mojica G, Hariprasad SM, Jager RD, Mieler WF: Short-Term Intraocular Pressure

Trends Following Intravitreal Injections of Ranibizumab (Lucentis) for the Treatment of Wet Age-Related Macular Degeneration. Br J Ophthalmol 92(4): 584, 2008.

Seenu M. Hariprasad

6

30. Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR: Voriconazole in the

Treatment of Fungal Eye Infections: a Review of Current Literature. Br J Ophthalmol 92: 871-878, 2008.

31. Hariprasad SM, Callanan D: Topical Nepafenac 0.1% for the Treatment of Chronic

Uveitic Cystoid Macular Edema. Retin Cases & Brief Rep 2(4): 304-308, 2008. 32. Mazzula A, Hariprasad SM, Jager RD, Mieler WF: Short-Term Intraocular Pressure

Trends after Intravitreal Injection of Bevacizumab (Avastin). Retin Cases & Brief Rep 2(3): 234-235, 2008.

33. Kiernan DF, Hariprasad SM, Chin EK, Kiernan CL, Rago J, Mieler WF: Prospective

Comparison of High-Definition-CirrusTM and StratusTM Optical Coherence Tomography for Quantifying Retinal Thickness. Am J Ophthalmology 147(2): 267-275, 2009.

34. Hariprasad SM, Akudman, L, Clever JA, Ober M, Recchia FM, Mieler WF: Treatment of

Cystoid Macular Edema with the New-Generation NSAID Nepafenac 0.1%. Clin Ophthalmol 3(1): 147-154, 2009.

35. Nguyen QD, Shah SM, Browning DJ, Hudson H, Sonkin P, Hariprasad SM, Kaiser P,

Slakter J, Haller J, Do DV, Mieler WF, Chu K, Yang K, Ingerman A, Vitti RL, Berliner AJ, Cedarbaum JM, Campochiaro PA: A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology 116(11): 2141-2148, 2009.

36. Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ,

Tolentino M, Chan CK, Gonzalez VH, SCORE Study Research Group: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 127(9): 1101-1114, 2009.

37. Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez

VH, Singerman LJ, Tolentino M, SCORE Study Research Group: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 127(9): 1115-1128, 2009.

38. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN, SCORE Study

Investigator Group: SCORE Study Report 7- incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design. Am J Ophthalmol 148(5): 725-732, 2009.

39. Gabrielian A, Mieler WF, Hariprasad SM: Retinal Artery Occlusion Associated with a

Patent Foramen Ovale. Eye 24(2): 396-397, 2010. 40. Kiernan DF, Mieler WF, Hariprasad SM. Spectral-Domain Optical Coherence

Tomography: A Comparison of Modern High-Resolution Retinal Imaging Systems. Am J Ophthalmol (Perspectives Invitation) 149(1): 18-31, 2010.

Seenu M. Hariprasad

7

41. Gabrielian A, Hariprasad SM, Jager RD, Green JL, Mieler WF: The Utility of Visual

Function Questionnaire in the Assessment of the Impact of Diabetic Retinopathy on Vision-Related Quality of Life. Eye 24(1): 29-35, 2010.

42. Gabrielian A, Hariprasad SM: New onset of bilateral multifocal coccidioidomycosal

choroiditis in a patient on oral fluconazole. Can J Ophthalmol 45(4): 419-420, 2010. 43. Collins ME, Hariprasad SM: Images in clinical medicine- Free-floating iris cyst. N Engl J

Med 362(18): 1720, 2010. 44. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG,

Murahashi WY; CRUISE Investigators: Ranibizumab for macular edema following central retinal vein occlusion- six-month primary end point results of a phase III study. Ophthalmology 117(6): 1124-1133, 2010.

45. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY,

Rubio RG; BRAVO Investigators: Ranibizumab for macular edema following branch retinal vein occlusion- six-month primary end point results of a phase III study. Ophthalmology 117(6): 1102-1112, 2010.

46. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein

A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group: Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117(6): 1134-1146, 2010.

47. Singh A, Hosseini M, Hariprasad SM: Polyethylene Glycol Hydrogel Polymer Sealant

for Closure of Sutureless Sclerotomies: A Histologic Study. Am J Ophthalmol 150(3): 346-351, 2010.

48. Kiernan DF, Mieler WF, Hariprasad SM. Variety, Variability and Veracity: Macular

thickness and reproducibility among optical coherence tomography systems. Am J Ophthalmol (Editorial Invitation) 150(2): 138-140, 2010.

49. Kiernan DF, Hariprasad SM, Rusu IM, Mehta SV, Mieler WF, Jager RD: Epidemiology

of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration. Retina 30(10): 1573-1578, 2010.

50. Stewart JM, Srivastava SK, Fung AE, Mahmoud TH, Telander DG, Hariprasad SM, Ober

MD, Mruthyunjaya P: Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Ocul Immunol Inflamm 19(1): 32-38, 2011.

51. Hariprasad SM, Singh A: Polyethylene glycol hydrogel polymer sealant for vitrectomy

surgery: an in vitro study of sutureless vitrectomy incision closure. Arch Ophthalmol 129(3): 322-325, 2011.

52. Kiernan DF, Shah RJ, Hariprasad SM, Grassi MA, Small KW, Kiernan JP, Mieler WF:

Thirty-Year Follow-up of an African American Family with Macular Dystrophy of the Retina, Locus 1 (North Carolina Macular Dystrophy). Ophthalmology 118(7): 1435-1443, 2011.

Seenu M. Hariprasad

8

53. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein

A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J: Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 118(12): 2453-2460, 2011.

54. Patel RD, Momi RS, Hariprasad SM: Review of ranibizumab trials for neovascular age-

related macular degeneration. Semin Ophthalmol 26(6): 372-379, 2011. 55. Afshar AR, Hariprasad SM, Jampol LM, Sheth VS: Use of intravitreous bevacizumab to

treat macular edema in West Nile virus chorioretinitis. Arch Ophthalmol 130(3): 396-398, 2012.

56. Kiernan DF, Zelkha R, Hariprasad SM, Lim JI, Blair MP, Mieler WF: En face spectral-

domain optical coherence tomography outer retinal analysis and relation to visual acuity. Retina 32(6): 1077-1086, 2012.

57. Campochiaro PA, Brown DM, Pearson A, Chen S, Boyer D, Ruiz-Moreno J, Garretson

B, Gupta A, Hariprasad SM, Bailey C, Reichel E, Soubrane G, Kapik B, Billman K, Kane FE, Green K; FAME Study Group: Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema. Ophthalmology 119(10): 2125-2132, 2012.

58. Ittiara S, Sanduja N, Hariprasad SM: Hot, Liquid Glass Injury as a Novel Mechanism for

Intraocular Foreign Body. Eye 26(8): 1145-1149, 2012. 59. Nguyen QD, Campochiaro PA, Shah SM, Browning DJ, Hudson HL, Sonkin PL,

Hariprasad SM, Kaiser PK, Slakter J, Haller JA, Do DV, Mieler W, Chu K, Ingerman A, Vitti R, Berliner AJ, Cedarbaum J; Clear-It 1 Investigators: Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. J Ocul Pharmacol Ther 28(6): 581-588, 2012.

60. Hariprasad SM, Morse LS, Shapiro H, Wong P, Tuomi L: Fixed Monthly versus Less

Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration. J of Ophthalmology EPUB Sept 2012.

61. Afshar AR, Fernandes JK, Patel RD, Ksiazek SM, Sheth VS, Reder AT, Hariprasad SM:

Cystoid macular edema associated with fingolimod use for multiple sclerosis. JAMA Ophthalmology 131(1): 103-107, 2013.

62. Patel R, Messner LV, Teitelbaum B, Michel KA, Hariprasad SM: Characterization of

Ischemic Index using Ultrawidefield Fluorescein Angiography in Patients with Focal and Diffuse Recalcitrant Diabetic Macular Edema. Am J Ophthalmol 155(6): 1038-1044, 2013.

63. Ober MD, Hariprasad SM: Ocriplasmin: Nonsurgical option for VMA and macular hole,

but with potential barriers to practical use. Ophthalmic Surg Lasers Imaging Retina 44(2): 113-116, 2013.

Seenu M. Hariprasad

9

64. Major JC, Hariprasad SM: Current concepts in managing wet AMD suboptimally responsive to anti-VEGF therapy. Ophthalmic Surg Lasers Imaging Retina 44(3): 225-226, 2013.

65. Busbee BG, Ho AC, Brown DM, Heier JS, Suñer IJ, Li Z, Rubio RG, Lai P; HARBOR

Study Group: Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology 120(5): 1046-1056, 2013.

66. Telander D, Hunter A, Hariprasad SM: The evolving paradigm for the treatment of

diabetic macular edema. Ophthalmic Surg Lasers Imaging Retina 44(4): 324-328, 2013. 67. Schneider EW, Mruthyunjaya P, Hariprasad SM: Combination therapy for macular

edema secondary to retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina 44(5): 434-438, 2013.

68. Kiernan DF, Hariprasad SM: Controversies in the management of Irvine-Gass syndrome.

Ophthalmic Surg Lasers Imaging Retina 44(6): 522-527, 2013. 69. Fine HF, Ober MD, Hariprasad SM: Current concepts in managing central serous

chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 45(1): 9-13, 2014. 70. Hellman JB, Garcia-Gonzalez JM, Lewis S, Hariprasad SM: Dexamethasone 0.7 mg

implant for the treatment of recalcitrant radiation maculopathy after proton radiotherapy for carcinoma of the maxillary sinus. J Ocul Dis Therapeutics 2: 30-35, 2014.

71. Walia HS, Shah GK, Hariprasad SM: ILM peeling a vital intervention for many

vitreoretinal disorders. Ophthalmic Surg Lasers Imaging Retina 45(2): 92-96, 2014. 72. Hariprasad SM, Puliafito CA: 8 Questions with Dr. Puliafito- interview with Seenu M.

Hariprasad, MD. Ophthalmic Surg Lasers Imaging Retina 45(2): 181-183, 2014. 73. Cunha-Vaz J, Ashton P, Iezzi R, Campochiaro P, Dugel PU, Holz FG, Weber M, Danis

RP, Kuppermann BD, Bailey C, Billman K, Kapik B, Kane F, Green K; FAME Study Group: Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema. Ophthalmology 121(10): 1892-1903, 2014.

74. Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H,

Hashad Y, Whitcup SM; Ozurdex MEAD Study Group: Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121(10): 1904-1914, 2014.

75. Sharma S, Hariprasad SM, Mahmoud TH: Surgical management of proliferative diabetic

retinopathy. Ophthalmic Surg Lasers Imaging Retina 45(3): 188-193, 2014. 76. Hellman JB, Fernandes JK, Patel RD, Hariprasad SM: Intravitreal dexamethasone

implant plus prompt grid laser for macular edema due to retinal vein occlusion. Ophthal Research Int J 2(6): 325-335, 2014.

Seenu M. Hariprasad

10

77. Williams PD, Hariprasad SM: Evolving trends in primary retinal detachment repair- microincisional vitrectomy and the role of OCT. Ophthalmic Surg Lasers Imaging Retina 45(4): 268-272, 2014.

78. Shukla SY, Afshar AR, Kiernan DF, Hariprasad SM: Outcomes of chronic macular hole

surgical repair. Indian J Ophthalmol 62(7): 795-798, 2014. 79. Colina J, Chen K, Snyder L, Hariprasad SM: A retrospective case study of the incidence

of endogenous fungal endophthalmitis in patients with positive blood cultures for systemic fungemia: review of the literature. Ophthal Research Int J 2(5): 250-258, 2014.

80. Tan CS, Sadda SR, Hariprasad SM: Ultra-widefield retinal imaging in the management of

diabetic eye diseases. Ophthalmic Surg Lasers Imaging Retina 45(5): 363-366, 2014.

81. Danzig C, Hariprasad SM: Surgical management of symptomatic vitreous floaters. Ophthalmic Surg Lasers Imaging Retina 45(6): 1-3, 2014.

82. Chew MC, Tan CS, Hariprasad SM: Optimal area of retinal photocoagulation necessary

for suppressing active iris neovascularization associated with diabetic retinopathy. Int Ophthalmol 35(2):155-156, 2015.

83. Lakhanpal RR, Hariprasad SM: Strategic planning ensures surgical success in cases of

proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging Retina 46(2): 155-157, 2015.

84. Press VG, Matthiesen MI, Ranadive A, Hariprasad SM, Meltzer DO, Arora VM: Insights

into inpatients with poor vision: A high value proposition. J Hosp Med 10(5): 311-313, 2015.

84. Saatci AO, Ayhan Z, Yüksel B, Seymenoğlu G, Hariprasad SM.: Intravitreal aflibercept

injection and photodynamic treatment of a patient with unilateral subretinal neovascular membrane associated with fundus flavimaculatus. Case Rep Ophthalmol Med Epub, 2015.

85. Wykoff CC, Hariprasad SM: Comparing aflibercept, bevacizumab, and ranibizumab for

DME- analysis of DRCR Protocol T. Ophthalmic Surg Lasers Imaging Retina 46(3): 302-305, 2015.

86. Calzada JI, Garrett TN, Hariprasad SM: Clinic design for a modern retina practice.

Ophthalmic Surg Lasers Imaging Retina 46(4): 406-411, 2015. 87. Shukla SY, Batra NN, Ittiara ST, Hariprasad SM: Reassessment of Scleral Depression in

the Clinical Setting. Ophthalmology Epub, 2015.

Non-Peer Reviewed Articles: 1. Moon SJ, Hariprasad SM, Bohra L, Allen RC: Posterior Polar Cataract- The Wolf Who Wore Sheep’s Clothing. EyeNet 6 (7): 35-37, 2002.

Seenu M. Hariprasad

11

2. Mieler WF, Hariprasad SM: New Generation Anti-Infectives: An Update for the Vitreoretinal Surgeon. Vitreoretinal Surgery & Technology Newsletter 12 (3): 9-12, 2003.

3. Mieler WF, Hariprasad SM: New Perspectives in the Management of Intraocular Infection. Vision Pan-America Newsletter 3: 14-15, 2004.

4. Hariprasad SM. Kenalog: Does It Still Fit in Clinical Practice?. Review of

Ophthalmology Vol. 13, No. 8, 2006.

5. Hariprasad SM, Shah GK: Alternatives and Advances in Adjuvant use for Vitreoretinal Surgery: A Focus on Triamcinolone Acetonide Assisted Internal Limiting Membrane Peeling. Review of Ophthalmology, 2005.

6. Hariprasad SM: Treating Cystoid Macular Edema with New-Generation NSAIDS.

Ophthalmology Management 36-37, 2007.

7. Hariprasad SM: Age-Related Macular Degeneration- An Update for the Non- Ophthalmologist. Chicago Medicine 110: 20-23, 2007.

8. Hariprasad SM: Treating Cystoid Macular Edema with an Ocular NSAID. Retinal Physician S:1-8, September 2007.

9. Rosenfeld PJ, Hariprasad SM, Reichel E, Apte RS, Brown DM: Maximizing Visual

Acuity Outcomes in AMD Therapy. Retinal Physician S:1-12, October 2007. 10. Hariprasad SM: The Increasing Use of New Generation NSAIDS in the Treatment of

Cystoid Macular Edema. Retinal Physician 74-76, December 2007. 11. Hariprasad SM, Do D, Fung AE, Ober MD: Minimizing the Risks of Intravitreal

Injections. Retinal Physician S: 1-16, March 2008. 12. Hariprasad SM: New Approaches to the Treatment of Cystoid Macular Edema.

Refractive Eyecare Vol. 12, No. 11, November 2008. 13. Hariprasad SM: Pharmacotechnology: Novel Methods to Deliver Ocular Drugs to

Improve Efficacy and Durability. Retinal Physician 43-48, December 2008. 14. Ober MD, Hariprasad SM: Retinal Lasers: Past, Present, and Future. Retinal Physician

36-39, February 2009. 15. Hariprasad SM: Clinical Cases- NSAIDs for Uveitic CME. Retina Today S: 1-8, March

2009.

16. Hariprasad SM, Benz MS, Lindstrom RL, Ober MD, Warren KA: Managing Cystoid Macular Edema- A Multidisciplinary Perspective. Retinal Physician S: 1-16, March, 2009.

17. Hariprasad SM: Practice Patterns- Diffuse Diabetic Macular Edema. Retina Times 34,

Spring 2009.

Seenu M. Hariprasad

12

16. Hariprasad SM, Muralidhar NS, Tang S, Murthy H, Nagpal M: Microincision Vitrectomy Surgery- Sutureless Safety. Ophthalmology World Report 12-20, April, 2009.

17. Kiernan DF, Hariprasad SM, Mieler WF: Modern High Resolution OCT Systems.

Ophthalmology International 3(4): 23-27, 2009.

18. Hariprasad SM, Gabrielian A: Increased Incidence of Sterile Endophthalmitis Following Intravitreal Preserved Triamcinolone Acetonide. Evidence-Based Ophthalmology 10(1): 31-32, January, 2009.

19. Hariprasad SM, Ober MD: New Approaches to Retina Laser Therapy. Retinal Physician

58-61, September, 2009. 20. Collins MD, Sheth V, Raichand S, Saidel MA, Hariprasad SM: Microincisional

Sutureless Vitrectomy for Dislocated IOL. Retina Today 32-35, November/December, 2009.

21. Hariprasad SM: Microincisional Vitrectomy Surgery for the Repair of Retinal

Detachment. Retinal Physician 62-64, November/December, 2009. 22. Murray T, Ho AC, Haller JA, Hariprasad SM: Intravitreal Corticosteroid- A Review of

Therapeutic and Surgical Applications. Retina Today S: 1-16, November/December, 2009.

23. Hariprasad SM: 5 Questions with Seenu M. Hariprasad, MD. Retina Today 82,

January/February, 2010. 24. Kiernan DF, Hariprasad SM: Normative Databases in SD-OCT- A Status Report. Retinal

Physician 16-29, April, 2010. 25. Hariprasad SM, Moshfeghi AA: Point/Counter- How has the introduction of spectral-

domain technology changed how ophthalmologists use OCT?. Ocular Surgery News 11, May 25, 2010.

26. Hariprasad SM, Sheth VS, Chiranand P: Combination Therapy for Retinal Vein

Occlusion. Retina Today 67-76, May/June, 2010. 27. Hariprasad SM, Hariprasad J: Chow-Town, Chicago Residents Point the Way to

Chicago’s Best Eateries. Ophthalmology Management 100-104, October, 2010. 28. Hariprasad SM: Hydrogel Bandage Minimizes Risks of Microincisional Vitrectomy

Surgery. Ocular Surgery News 30-31, September 10, 2010. 29. Hariprasad SM, Moshfeghi AA, Dugel PU: Better Instrument Design, Increased

Indications Boost Popularity of Microincisional Vitrectomy Surgery. Ocular Surgery News Cover Story, September 25, 2010.

30. Boyer DS, Cidlowski JA, Csaky KG, Hariprasad SM, Kiss S: The Use of Steroids for

Clinically Significant Macular Edema. Retina Today S: 1-16, September, 2010.

Seenu M. Hariprasad

13

31. Hariprasad SM, Mah FS: New Approaches in the Treatment of Ocular Inflammation of the Anterior and Posterior Segment Following Surgery. Peer View in Review CME Activity, September, 2010. www.peerviewpress.com/i1/r154

32. Hariprasad SM: Vitamin Supplementation and Progression of AMD: An AREDS Update.

Ophthalmology Times, October, 2010. 33. Gallemore RP, Hariprasad SM, Eaton A, Warren KA, Miller DM: Topical Steroids for

Therapeutic Use in the Posterior Segment. Retina Today S: 1-16, November/December, 2010.

34. Hariprasad SM, Patel RD, Kitchens JW: The Uncharted Realm of the Retinal Periphery.

Retinal Physician Cover Story, 33-40, January, 2011. 35. Kiernan DF, Hariprasad SM: Controversies in Managing Macular Edema Secondary to

Retinal Vein Occlusion- How Does Ocular Imaging Guide Treatment? Retinal Physician, 28-35, April, 2011.

36. Hariprasad SM, Ip M: Extended dosing regimen for AMD treatment may spur increased

use of OCT. Ocular Surgery News 19-20, July 25, 2011. 37. Haller JA, Hariprasad SM, Boyer DS, Ip MS, Kiss S: Sustained-release and combination

therapies may be future of retinal treatment. Ocular Surgery News Cover Story, November 10, 2011.

38. Batra N, Hariprasad SM: Combined Hamartoma of the Retina and RPE. Ocular Surgery

News Retina- CONNECT Network’s What’s Your Diagnosis?, 5-6, January 25, 2012. 39. Hariprasad SM: Macula Report- Planning for AREDS2. Retinal Physician, 19-23,

October, 2012. 40. Hariprasad SM, Bandello F, Moshfeghi A: Research Drives Treatment Options for

Macular Edema Secondary to Retinal Vein Occlusion. Ocular Surgery News Cover Story, October 10, 2012.

41. Agrawal KK, Hariprasad SM: Sympathetic Ophthalmia. Retina- CONNECT Network’s

What’s Your Diagnosis?, Ocular Surgery News 5-6, December 25, 2012. 42. Hariprasad SM, Azad R, Ohji M, Kwak HW, Natarajan S: Age-Related Macular

Degeneration- Experts’ Corner. Delhi Ophthalmological Society Times, 13-16, September, 2013.

43. Patel RD, Hariprasad SM: Taking a Wider View in the Treatment of DME. Retinal

Physician, 26-33, September, 2013. 44. Kaiser P, Hariprasad SM, Ehlers J, Jain A, Slakter J: Insights on Switching Anti-VEGF

Agents for Optimal AMD Treatment. Retinal Physician Supplement, 1-15, September, 2013.

45. Campochiaro PA, Hariprasad SM, Fekrat S, Lin P, McCannel CA: Untangling RVO-

Treatment Tips from 5 Experts. EyeNet Cover Story, 54-61, November, 2013.

Seenu M. Hariprasad

14

46. Hariprasad SM, Brown DM, Dugel PU, Mansour SE, Boyer D: Retina specialists

examine evolving role of laser therapy in DME treatment. Ocular Surgery News Cover Story, January 10, 2014.

47. Hariprasad SM, Kumar A, Natarajan S, Verma L, Shroff CM: Experts’ Corner-

Endophthalmitis. Delhi Ophthalmological Society Newsletter, 11-16, March, 2014. 48. Hariprasad SM, Schneider EW, Dugel PU, Gallamore R, Haller J, Capone A: Multi-

modality treatment approaches to RVO associated macular edema- macular laser in the RVO treatment paradigm. Retinal Physician Supplement, 1-20, April, 2014.

49. Hariprasad SM, Bakri, SJ, Awh, CC: Managing intraoperative complications. New

Retinal Physician, 6-10, July, 2014. 50. Hariprasad SM, Brown DM, Kim JE, Kiss S, Bloomgarden ZT: Advances in imaging

technologies improve screening, detection of diabetic eye disease. Ocular Surgery News Cover Story, August 25, 2014.

51. Hariprasad SM: In Focus- Advances in AMD: Clinical Case- Starting therapy in a patient

newly diagnosed with wet AMD. http://www.retinacme.com/age-related-macular-degeneration/2014/10_october/in-focus-advances-in-amd-clinical-case-starting-therapy-in-a-newly-diagnosed-amd-patient/cme-information, August, 2014.

52. Hariprasad SM, Hovanesian JA, Agarwal A, Saidel MA, Devgan U: Wound architecture,

size dictate cataract surgery outcomes. Ocular Surgery News Cover Story, September 10, 2014.

53. Hariprasad SM: Striking a happy balance. New Retinal Physician, 16-18, September,

2014. 54. Hariprasad SM, Holekamp NM, Bakri SJ, Graff JM, Wykoff C, Weber PA: Hit the

ground running. New Retinal Physician, 16-18, September, 2014. 55. Hariprasad SM, Azad R, Natarajan S, Ohji M, Kwak HW: Experts’ Corner- Age related

macular degeneration. Delhi Ophthalmological Society Newsletter, 13-15, September, 2014.

56. Tan CS, Hariprasad SM: Ultrawidefield Imaging in Diabetic Retinal Disease. Retinal

Physician, 33-37, November, 2014. 57. Sheth VS, Hariprasad SM: DME drugs multiply. Ophthalmology Mgmt, 16-18,

November, 2014. 58. Brown DM, Hariprasad SM, Kaiser PK, Mahmoud TH, Philipson L: Integrated cross-

disciplinary approaches to the management of diabetic eye diseases. Retinal Physician, 1-16, March, 2015.

59. Colucciello M, Kiss S, Hariprasad SM: Controversies in care- Widefield angiography-

guided laser photocoagulation for recalcitrant macular edema in retinal vascular disease. Retinal Physician, 1-16, April, 2015.

Seenu M. Hariprasad

15

60. Boyer DS, Fine HF, Khurana RN, Ober MD, Sheth VS, Singer MA, Hariprasad SM:

Evolving strategies in the use of corticosteroids for the treatment of DME. Retinal Physician, 1-20, April, 2015.

61. Hariprasad SM, Dugel PU, Kiernan D, Kurup SK, Maturi R, Shah GK, Singer MA,

Wykoff CC: Emerging concepts in the use of combination therapy for the treatment of DME. Retinal Physician, 1-16, May, 2015.

Abstracts / Posters:

1. Hariprasad SM, et al.: Quantitation of Peritoneal Dialysis: Computerized Urea Kinetic Modeling. JASN, 1:387, 1990. 2. Hariprasad SM, et al.: Dialysis Calculator: A Low Cost Practical Software For Hemodialysis Units. Kidney International, 37:300, 1990. 3. Hariprasad SM, et al.: Computerized Urea Kinetic Modeling: Results of a Premarketing Survey. Kidney International, 37:300, 1990. 4. Hariprasad SM, et al.: Salt Prescription for Peritoneal Dialysis Patients. Presented at the End Stage Renal Disease Network of New York Annual Meeting, New York, NY, 1994. 5. Hariprasad SM, et al.: Nursing Home Peritoneal Dialysis Experience. Presented

at the End Stage Renal Disease Network of New York Annual Meeting, New York, NY, 1994.

6. Piltz J, Grunwald JE, DuPont J, Hariprasad SM: Optic Nerve Head Hemodynamics in

Glaucoma. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1997.

7. Piltz JR, Grunwald JE, DuPont J, Hariprasad SM: Systemic Hypertension and Optic

Nerve Head Circulation in Glaucoma. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1998.

8. DuPont J, Piltz JR, Grunwald JE, Hariprasad SM: The Relationship Between Optic Nerve

Circulation, Blood Pressure, Optic Disc and Visual Field Variables in Glaucoma. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1999.

9. Ebenezer ND, Patel C, Hariprasad SM, Chen LL, Patel RJ, Bhattacharya SS, Webster

AR, Allen RC: A novel mutation in keratocan causes autosomal recessive Cornea Plana (CNA2). Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 2002.

10. Shah GK, Hariprasad SM, Breit S, Mieler WF, Grand MG, VanGelder R: Treatment of

Endogenous Fungal Endophthalmitis with Systemic and Intravitreal Voriconazole: A Clinical and Penetration Pharmacokinetic Study. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 2004.

Seenu M. Hariprasad

16

11. Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Grand MG, Thomas MA, Holekamp NM, Mieler WF, Prince RA: Determination of Vitreous and Aqueous Concentration of Topically Administered Moxifloxacin 0.5% in Humans. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 2004.

12. Grand MG, Hariprasad SM, Shah GK, Mieler WF, Breit S, VanGelder R: New Treatment Options for Managing Endogenous Fungal Endophthalmitis Using Voriconazole and Caspofungin. Presented at the 140th Annual Meeting of the American Ophthalmological Society, Hot Springs, VA, May 24, 2004. 13. Prasad A, Hariprasad SM, Smith M, Shah GK, Grand MG, Shepherd JB, Wickens J, Apte RS, Liao R, VanGelder R: Bilateral Choroiditis from Prototheca Wickerhamii Algaemia. Presented at the 22nd Annual Meeting of the American Society of Retina Specialists, San Diego, CA, August 17th, 2004.

14. Hariprasad SM, Shah GK: Treatment of Juxtafoveal Choroidal Neovascularization with Photodynamic Therapy Using Verteporfin in Eyes with Age-Related Macular Degeneration. Presented at the 22nd Annual Meeting of the American Society of Retina Specialists, San Diego, CA, August 17th, 2004.

15. Lee E, Hariprasad SM, Mieler WF: Short-Term Intraocular Pressure Trends After Intravitreal Triamcinolone Injection. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, April 30, 2006. 16. Alexandrou TJ, Hariprasad SM, Mieler WF, Saidel WA, Ksiazek S, Rubin MP, Benevento J, Thompson K, Boonlayangoor S: Elimination of Conjunctival Bacterial Flora With the Use of Mupirocin Nasal Ointment. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1, 2006. 17. Yeh JC, Hariprasad SM, Benevento J, Mieler WF: Comparison of Efficacy Between Intravitreal and Periocular Injection of Triamcinolone Acetonide for Refractory Pseudophakic Cystoid Macular Edema. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2006. 18. Benevento JD, Hariprasad SM, Mieler WF: Visual Acuity Outcomes After Epiretinal Membrane Removal Using 25 Gauge Vitrectomy and Triamcinolone Acetonide Assisted Peeling of the Internal Limiting Membrane. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2006.

19. Shah SM, Nguyen QD, Hariprasad SM, Chu K, Holekamp N, Buskey J, Nadler D, Cederbaum J, Campochiaro PA: A Double-Masked, Placebo-Controlled, Safety, and Tolerability Study of Intravenous VEGF Trap in Patients With Diabetic Macular Edema. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2006.

20. Nguyen QD, Shah SM, Browning D, Sonkin P, Hudson H, Hariprasad SM, Chu K, Rich

K, Lucas A, Ingerman A, Cedarbaum J, Campochiaro PA. Results of a Phase I, Dose-Escalation, Safety Tolerability, and Bioactivity Study of Intravitreous VEGF Trap in Patients With Neovascular Age-Related Macular Degeneration. Presented at the

Seenu M. Hariprasad

17

Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2006.

21. Alexandrou TJ, Hariprasad SM, Benevento J, Mieler WF. Reduction of Pre-Operative

Conjunctival Bacterial Flora with the Use of Mupirocin Nasal Ointment. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 6, 2007.

22. Johnson VI, Hariprasad SM, Grassi MA, Green J, Jager RD, Mieler WF. The Impact of

Diabetic Retinopathy on Vision-Related Quality of Life. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 6, 2007.

23. Mojica GJ, Hariprasad SM, Radhakrishnan C, Mazzulla DA, Mieler WF. Short-Term

Intraocular Pressure Trends Following Intravitreal Injection of Ranibizumab (Lucentis) for the Treatment of Age-Related Macular Degeneration. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 6, 2007.

24. Mazzulla DA, Hariprasad SM, Mojica G, Radhakrishnan C, Jager RD, Mieler WF.

Short-Term Intraocular Pressure Trends Following Intravitreal Injection of Bevacizumab (Avastin). Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 6, 2007.

25. Benevento JD, Alexandrou TJ, Hariprasad SM, Mazzulla A, Mieler WF. Nasal Bacteria

as a Source of Contamination During Intraocular Surgery. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 6, 2007.

26. Belsare G, Hariprasad SM, Jager RD, Mazzulla DA, Mieler WF. Effects on Visual

Acuity and OCT Following Older Generation AMD Treatment with Subsequent Lucentis or Avastin Intravitreal Injections. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2007.

27. Lin RC, Hariprasad SM: Pars Plana Vitrectomy for Non Clearing Vitreous Hemorrhage.

Outcomes by Diagnosis and Timing of Surgery. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2007.

28. Hariprasad SM, Kaiser P, Slakter J, Nguyen QD, Williams D, Chu K, Grimes I, Ingerman

A, Cedarbaum JM, CLEAR-IT 1 Investigators. Optical Coherence Tomography Outcomes of a Phase I, Dose-Escalation, Safety, Tolerability, and Bioactivity Study of Intravitreal VEGF Trap in Patients with Neovascular Age-Related Macular Degeneration: The CLEAR-IT 1 Study. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2007.

29. Chang JC, Hariprasad SM, Benevento J, Mieler WF. Efficacy of 25-Gauge Vitrectomy,

ILM Peeling, and Gas Fluid Exchange for Closing Chronic Macular Holes. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2007.

30. Miller L, Mojica G, Hariprasad SM, Mieler WF, Grassi MA, Green JL, Jager RD.

Vision-Related Quality of Life in Patients with Diabetic Macular Edema. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 10, 2007.

Seenu M. Hariprasad

18

31. Warren K, Hariprasad SM, Callanan D, Gainey S. Treatment of Acute and Chronic

Cystoid Macular Edema with Nepafenac 0.1% (Nevanac). Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 10, 2007.

32. Hariprasad SM, Mieler WF. Treatment of Acute Pseudophakic, Chronic Pseudophakic,

and Recalcitrant Uveitic Cystoid Macular Edema with Nepafenac 0.1% (Nevanac). Presented at the 40th Annual Meeting of The Retina Society, Boston, MA, September 28, 2007.

33. Hariprasad SM, Warren KA, Gainey Steven, He YG, Callanan DG. Treatment of Acute

Pseudophakic, Chronic Pseudophakic, and Recalcitrant Uveitic Cystoid Macular Edema with Nepafenac 0.1%. Presented at the American Academy of Ophthalmology Meeting, New Orleans, LA, November 11, 2007.

34. Chang JC, Kiernan DF, Hariprasad SM, Belsare G, Gabrielian A, Patel S, Mieler WF.

Acquisition Time and Learning Curve Analysis of High-Definition CirrusTM Optical Coherence Tomography Compared to Standard-Resolution StratusTM OCT Among Ophthalmology Residents. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, April 27, 2008.

35. Alexandrou TJ, Hariprasad SM, Mieler WF. Pre-Operative Reduction of Nasal and

Conjunctival Bacterial Flora With the Use of Mupirocin Nasal Ointment: A Comparison of 3 vs. 5 Day Administration of Mupirocin. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, April 27, 2008.

36. Dave AJ, Gabrielian A, Lin R, Lin T, Hariprasad SM, Jager R, Rago J, Ernest J, Arun V.

A Comparison of Optical Coherence Tomography (OCT) and Fluorescein Angiography (FA) in The Diagnosis and Assessment of Diabetic Macular Edema. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, April 29, 2008.

37. Gabrielian A, Kiernan DF, Hariprasad SM, Lin T, Mieler WF. Effect of Intravitreal

Bevacizumab for Retinal Disease on Injected and Fellow Eyes. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, April 30, 2008.

38. Chin EK, Kiernan DF, Hariprasad SM, Singh R, Mieler WF. Superior Surgical Outcomes

of 25- over 20-Gauge Transconjunctival Vitrectomy Combined With Cataract Surgery for Vitreoretinal Diseases. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, April 30, 2008.

39. Lin RC, Mehta S, Hariprasad SM. Outcomes of Pars Plana Vitrectomy for Vitreous

Hemorrhage Based on Duration and Etiology of Hemorrhage. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1, 2008.

40. Burrell GJ, Hariprasad SM, Mieler WF, Jager RD. Improvement in Visual Quality of Life

After Traditional and Microincisional Vitrectomy Surgery. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1, 2008.

Seenu M. Hariprasad

19

41. Kiernan DK, Hariprasad SM, Kiernan CL, Chin E, Mieler WF. Prospective Comparison

of Cirrus Spectral Domain OCT vs. Stratus Time Domain OCT for Quantifying Macular Thickness. Presented at the American Academy of Ophthalmology Meeting, Atlanta, GA, November 10, 2008.

42. Stewart JM, Mruthyunjaya P, Fung AE, Mahmoud TH, Hariprasad SM, Srivastava SK,

Telander DG. Bacterial Contamination of Needles used for Intravitreal Injections: A Prospective, Multicenter Study. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2009.

43. Gabrielian A, Sheth V, Hariprasad SM. Surgical Outcomes of Epiretinal Membrane

Removal With and Without Internal Limiting Membrane Peel in Patients with Tractional Retinal Detachment. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2009.

44. Afshar AR, Kiernan DF, Hariprasad SM. Surgical Repair of Chronic Macular Holes.

Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2009.

45. Mehta SV, Lin RC, Hariprasad SM. Outcomes of Pars Plana Vitrectomy for Vitreous

Hemorrhage Based on Duration and Etiology of Hemorrhage. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2009.

46. Hariprasad SM, Sanders M, Chastain J, Curtis M, Faulkner R, Dahlin D. Periocular

Distribution of Nepafenac and Amfenac after Topical Administration of Nepafenac in the Rabbit. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2009.

47. Ober MD, Rosen R, Hariprasad SM, Neubauer A, Teiwes W, Weber U, Gabel-Pfisterer

A. An Introduction to the NAVILAS: A Significant Technological Advance in the Management of Retinal Diseases. Presented at the Retina Congress, New York, NY, October 1, 2009.

48. Hariprasad SM, Kiernan DF, Singh A, Afshar AR. Chronic Macular Hole Repair with the

use of 25g Microincisional Vitrectomy Surgery. Presented at the Retina Congress, New York, NY, October 1, 2009.

49. Chan A, Hariprasad SM, Chung CY, Wong P, Tuomi L. Delayed Responders in the

Treatment of Neovascular Age-Related Macular Degeneration (AMD) With Ranibizumab in the MARINA, ANCHOR, PIER and SAILOR Studies. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 2, 2010.

50. Chen JJ, Eulo V, Huang Y, Rehman J, Hariprasad SM, Jager RD, Sheth V, Nicolae DL,

Lussier VA, Grassi MA. Study of Genetic Expression in Diabetic Retinopathy Reveals Unique Molecular Fingerprint. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 2, 2010.

Seenu M. Hariprasad

20

51. Gabrielian A, Hariprasad SM. Incidence of Secondary Glaucoma Following Silicone Oil Use After Vitrectomy Surgery: A Retrospective Chart Review. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2010.

52. Singh A, Hosseini M, Hariprasad SM. Hydrogel Bandage for Vitrectomy Surgery: A

Histopathologic India Ink Study. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 4, 2010.

53. Hariprasad SM, Ober MD, Neubauer AS, Kernt M, Freeman WR, Kozak I. The Learning

Curve for Performing Focal Retina Laser With the NAVILAS®. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2010.

54. Mojica GJ, Fernandes JK, Hariprasad SM. Evaluation of Intravitreal Dexamethasone

Implant (OzurdexTM) in the Treatment of Refractory Macular Edema in Patients With Retinal Vein Occlusions. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2010.

55. Colina-Luquez JM, Mojica G, Sheth V, Hariprasad SM. Incidence of Endogenous Fungal

Endophthalmitis in Patients With Positive Blood Cultures for Systemic Fungemia. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 6, 2010.

56. Ansari AS, Towle VL, Roth S, Hariprasad SM, Chaudhary N, Gemmete JJ. Vessel

Deconstruction of the Ophthalmic Artery: Potential Diagnostic Utility of Balloon Test Occlusion Study with Electroretinography. Presented at the Society of Neurointerventional Surgery Annual Meeting, Carlsbad, CA, July 27, 2010.

57. Hariprasad SM, Morse LS, Shapiro H, Wong P, Chan A, Tuomi L: Delayed 15-Letter

Responders to Ranibizumab for Neovascular AMD in MARINA, ANCHOR, PIER, and SAILOR. Presented at the American Academy of Ophthalmology Meeting, Chicago, IL, October 17, 2010.

58. Shah RJ, Kiernan DF, Hariprasad SM, Grassi MA, Kiernan JP, Small KW, Mieler WF:

Thirty Year Follow-Up of an African-American Family With North Carolina Macular Dystrophy. Presented at the American Academy of Ophthalmology Meeting, Chicago, IL, October 17, 2010.

59. Patel RD, Hariprasad SM, Messner LV, Teitelbaum B, Michel K. Examining Recalcitrant

Diabetic Macular Edema with Optos Wide-Field Fluorescein Angiography. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1, 2011.

60. Fernandes JK, Chiranand P, Hariprasad SM. Evaluation Of An Intravitreal

Dexamethasone Implant (OzurdexTm) Plus Prompt Focal Laser For Macular Edema Secondary To Retinal Vein Occlusions. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 2, 2011.

61. Singh A, Hariprasad SM. Polyethylene Glycol Hydrogel Polymer Sealant for Sutureless

Pars Plana Vitrectomy Surgery: An in vitro study of sutureless incision closure. Presented

Seenu M. Hariprasad

21

at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2011.

62. Fernandes JK, Patel R, Hariprasad SM. Combination Therapy of an Intravitreal

Dexamethasone Implant (OzurdexTM) Plus Prompt Focal Laser for Macular Edema Secondary to Retinal Vein Occlusions - 12 Month Follow-up. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 6, 2012.

63. Hariprasad SM, Patel R. Fluorescein Angiographic Features of Recalcitrant Diabetic

Macular Edema Using Optos Wide-Field Imaging. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2012.

64. Ittiara S, Lin RC, Patel R, Hariprasad SM. Outcomes of 20, 23, and 25 Gauge Pars Plana Vitrectomy for Dense Vitreous Hemorrhage Based on Etiology and Duration. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 8, 2012.

65. Speilburg AM, Ittiara S, Pang Y, Leong DF, Patel RD, Messner LV, Hariprasad SM. Is

Peripheral Retinal Ischemia Associated with Systemic Atherosclerosis? Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2013.

66. Batra NN, Patel RD, Ittiara S, Hariprasad SM, Heier JS. The Utility of Scleral Depression

for Detecting Peripheral Vitreoretinal Pathology. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2013.

67. Agrawal KK, Chen R, Ittiara S, Patel RD, Hariprasad SM. Comparison of the Relative

Efficacy of Aflibercept in the Treatment of Neovascular Age Related Macular Degeneration in Patients Previously Treated with Alternative Vascular Endothelial Growth Factor Inhibitors. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 7, 2013.

68. Marx JL, Moshfeghi DM, Hariprasad SM, Heier JS. Correlation Between Fluid Status at

Week 12 and Week 52 Following Intravitreal Aflibercept Injections in the VIEW study of wAMD Patients. Presented at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 9, 2013.

69. Shapiro MI, Louis AJ, Moreira V, Ranadive AS, Hougham GW, Hariprasad SM, Meltzer

DO, Arora VM, Press VG. Envisioned: Examining Vision among Inpatients with Diabetes. Presented at the Society of Hospital Medicine Annual Meeting, Las Vegas, March 25, 2014.

70. Shapiro MI, Schoenfeld E, Louis AJ, Ranadive AS, Hougham GW, Hariprasad SM,

Meltzer DO, Arora VM, Press VG. Seeing is believing: Vision-related Quality of Life among Hospitalized Patients. Presented at the Society of Hospital Medicine Annual Meeting, Las Vegas, March 26, 2014.

71. Shapiro MI, Arora VM, Louis AJ, Schoenfeld E, Ranadive AS, Hougham GW,

Hariprasad SM, Meltzer DO, Press VG. Seeing is believing: Vision-related Quality of

Seenu M. Hariprasad

22

Life among Hospitalized Patients. Presented at the Society of General Internal Medicine Annual Meeting, San Diego, April 25, 2014.

72. Shapiro MI, Arora VM, Louis AJ, Moreira V, Ranadive AS, Hougham GW, Hariprasad

SM, Meltzer DO, Press VG. Seeing the Light: Examining VISion among Inpatients with Diabetes (EnVISIONeD Study). Presented at the Society of General Internal Medicine Annual Meeting, San Diego, April 25, 2014.

73. Agrawal KK, Chen R, Patel RD, Ittiara S, Hariprasad SM. Assessment of Quality of Life

in patients with Neovascular Age Related Macular Degeneration who switch therapy to Aflibercept. Presented at the Association for Research in Vision and Ophthalmology Meeting, Orlando, FL, May 4, 2014.

74. Chen K, Colina J, Snyder L, Hariprasad SM. A Retrospective Case Study of the

Incidence of Endogenous Fungal Endophthalmitis in Patients with Positive Blood Cultures for Systemic Fungemia: Review of the Literature. Presented at the Association for Research in Vision and Ophthalmology Meeting, Orlando, FL, May 6, 2014.

75. Hariprasad SM, Yao L, Sternberg G. Effect of Alternate Ranibizumab Dosing Regimens

on Visual and Anatomic Outcomes in Patients with Retinal Vein Occlusion—The SHORE Study. Presented at the Association for Research in Vision and Ophthalmology Meeting, Orlando, FL, May 6, 2014.

76. Shukla SY, Batra NN, Patel RD, Ittiara S, Hariprasad SM: Reassessment of Scleral

Depression in the Clinical Setting. Presented at the American Academy of Ophthalmology Meeting, Chicago, IL, October 18, 2014.

77. Williams B, Nariani A, Poudyal S, Hariprasad SM. Long-term effects of anti-VEGF

injections on intraocular pressure in patients with age-related macular degeneration and diabetic macular edema. Presented at the Association for Research in Vision and Ophthalmology Meeting, Denver, CO, May 4, 2015.

Meeting Presentations: 1. Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, Maguire

AM, Ho AC: Foveolar Choroidal Blood Flow in Age-Related Macular Degeneration. Presented at The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1997.

2. Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, Ho AC, Maguire AM: Systemic Hypertension and Choroidal Blood Flow in Age- Related Macular Degeneration. Presented at The Association for Research in Vision and

Ophthalmology Meeting, Fort Lauderdale, FL, May 1998. 3. Piltz JR, Grunwald JE, DuPont J, Hariprasad SM: Decreased Optic Nerve Blood Flow Precedes Field Defects in Glaucoma Suspect Eyes. Presented at The Association for

Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 1999.

4. Hariprasad SM, Mieler WF, Holz ER: Vitreous Penetration of Orally Administered Gatifloxacin in Humans. Presented at the 138th Annual Meeting of the American

Seenu M. Hariprasad

23

Ophthalmological Society, Sea Island, GA, May 21, 2002.

5. Gao H, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER: Safety of Intravitreal Voriconazole- Histopathologic and Electroretinographic Study. Presented at the 139th Annual Meeting of the American Ophthalmological Society, Santa Barbara, CA, May 18, 2003.

6. Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, Prince RA: Determination of Vitreous, Aqueous, and Plasma Concentration of Orally Administered Voriconazole in Humans. Presented at the 36th Annual Meeting of The Retina Society, Chicago, IL, September 20, 2003. 7. Mieler WF, Gao H, Pennesi M, Iyer M, Hariprasad SM, Grand MG, Shah GK, Blinder KJ, Holekamp NM, Thomas MA, Apte R: Moxifloxacin: Topical and Intravitreal Administration. Presented at the Annual Meeting of The Macula Society, Las Vegas, NV, February 2004.

8. Grand MG, Hariprasad SM, Shah GK, Mieler WF: The Role of Systemic and Intravitreal Voriconazole in the Management of Endogenous Fungal Endophthalmitis. Presented at the Annual Meeting of The Macula Society, Las Vegas, NV, February 2004.

9. Hariprasad SM, Mieler WF, Blinder KJ, Shah GK, Apte RS, Holekamp NM, Thomas MA, Chi J, Prince RA: Human Intraocular Penetration Pharmacokinetics of Moxifloxacin 0.5% via Topical and Collagen Shield Routes of Administration. Presented at the 140th

Annual Meeting of the American Ophthalmological Society, Hot Springs, VA, May 25, 2004. 10. Hariprasad SM: Advances in the Anti-Microbial Treatment of Endophthalmitis-The

Expanding Role of Systemic Antibiotics. Presented at The Association for Research in Vision and Ophthalmology Retina Symposium, Fort Lauderdale, FL, May 1-3, 2006.

11. Nguyen QD, Shah SM, Browning D, Sonkin P, Hudson H, Hariprasad S, Chu K, Rich K,

Lucas A, Ingerman A, Cedarbaum J, Campochiaro PA: Results of a Phase I, Dose Escalation, Safety, Tolerability, and Bioactivity Study of Intravitreous VEGF Trap in Patients With Neovascular Age-Related Macular Degeneration. Presented at The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2006.

12. Hariprasad SM, Chu K, Cedarbaum J, Campochiaro P, Browning D, Sonkin P, Hudson

H, Nguyen QD, Mieler WF: C.L.E.A.R-IT 1: A Phase I Safety, Tolerability and Bioactivity Study of Intravitreous VEGF Trap in Patients with Neovascular Age-Related Macular Degeneration. Presented for the 6th EURETINA Congress, Lisbon, Portugal, May 19, 2006.

13. Alexandrou TJ, Hariprasad SM, Mieler WF, Saidel M, Ksiazek S, Rubin MP, Benevento

J, Boonlayangoor S, Thompson K: Elimination of Pre-Operative Conjunctival Bacterial Flora with the use of Mupirocin Nasal Ointment. Presented at the 142nd Annual Meeting of the American Ophthalmological Society, Half Moon Bay, CA, May 21, 2006.

14. Nguyen QD, Hariprasad SM, Shah SM, Browning D, Sonkin P, Hudson H, Haller A, Chu K, Rich K, Lucas A, Grimes I, Ingerman A, Cedarbaum J, Campochiaro PA: Results of a

Seenu M. Hariprasad

24

Phase I, Dose-Escalation, Safety, Tolerability, and Bioactivity Study of Intravitreal VEGF Trap in Patients With Neovascular Age-Related Macular Degeneration: The CLEAR-IT 1 Study. Presented at the Club Jules Gonin Retina Society Meeting, Cape Town, South Africa, October 18, 2006.

15. Hariprasad SM, Mieler WF, Nguyen QD, Kaiser P, Slakter J, Shah SM, Browning D,

Sonkin P, Hudson H, Chu K, Rich K, Lucas A, Grimes I, Ingerman A, Cedarbaum J, Campochiaro PA, and CLEAR-IT team: Fluorescein Angiographic and OCT Outcomes of a Phase I, Dose-Escalation, Safety, Tolerability, and Bioactivity Study of Intravitreal VEGF Trap in Patients With Neovascular AMD: The CLEAR-IT 1 Study. Presented at the Club Jules Gonin Retina Society Meeting, Cape Town, South Africa, October 18, 2006.

16. Vemulakonda A, Hariprasad SM, Mieler WF, Prince R, Shah GK, Van Gelder RN:

Determination of Aqueous and Vitreous Concentration of Topically Administered 1% Voriconazole in Humans. Presented at the 110th Annual Meeting of the American Academy of Ophthalmology, Las Vegas, NV, November 13, 2006.

17. Nguyen QD, Hariprasad SM, Mieler WF, Browning DJ, Sonkin PL, Hudson HL, Haller

JA, Lucas A, Chu K, Grimes I, Ingerman A, Cedarbaum J, Campochiaro PA: CLEAR-IT: A Phase 1 Safety, Tolerability, and Bioactivity Study of Intravitreal VEGF Trap in Patients With Neovascular AMD. Presented at the 110th Annual Meeting of the American Academy of Ophthalmology, Las Vegas, NV, November 13, 2006.

18. Nguyen QD, Hariprasad SM, Browning D, Sonkin P, Hudson H, Chu K, Ingerman A,

Cedarbaum J, Campochiaro PA: Results of a Phase I, Safety, Tolerability, and Bioactivity Study of Intravitreal VEGF Trap in Patients with Neovascular Age-Related Macular Degeneration: The CLEAR- IT 1 Study. Presented at The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 8, 2007.

19. Kiernan DF, Hariprasad SM, Praley A, Mazzulla DA, Mieler WF: Intravitreally Injected

Anti-VEGF Drugs Exert an Effect on Visual Acuity in the Fellow Eye. Presented at The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 10, 2007.

20. Hariprasad SM for the MARINA Study Group: Time Course of Visual Acuity Changes

with Ranibizumab in the 2-year MARINA Study of Patients with Neovascular Age-Related Macular Degeneration (AMD). Presented at the American Society of Retina Specialists Meeting, Palm Springs, CA, December 2, 2007.

21. Hariprasad SM, Akudman, L, Clever J, Ober M: Use of Nepafenac 0.1% to Treat Acute

Pseudophakic, Chronic/Recalcitrant Pseudophakic, and Uveitic Cystoid Macular Edema. Presented at the American Society of Cataract and Refractive Specialists Meeting, Chicago, IL, April 6, 2008.

22. Kiernan DF, Hariprasad SM, Rago JA, Singh R, Chin E, Mieler WF: Prospective

Comparison of High-Definition-CirrusTM Optical Coherence Tomography versus Standard-Resolution StratusTM OCT for Quantifying Central Macular Thickness. Presented at The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, April 28, 2008.

Seenu M. Hariprasad

25

23. Kiernan DF, Hariprasad SM, Singh R, Jager RD, Mieler WF: The Association of Daily Anticoagulant Use and Intraocular Hemorrhage in Patients with Neovascular Age-Related Macular Degeneration. Presented at The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2009.

24. Stewart J, Mruthyunjaya P, Srivastava SK, Fung AE, Mahmoud TH, Telander DG,

Hariprasad SM. Bacterial Contamination of Needles used for Intravitreal Injections: Results of a Prospective, Multicenter Study. Presented at the Retina Congress, New York, NY, October 2, 2009.

25. Kiernan DF, Zelkha RU, Lim JI, Hariprasad SM, Mieler WF: En Face Visualization and

Quantification of Photoreceptor Inner/ Outer Segment Junction Using Cirrus Spectral Domain Optical Coherence Tomography and Association With Visual Acuity. Presented at The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2010.

26. Shah RJ, Kiernan DF, Mieler WF, Grassi MA, Small KW, Kiernan JP, Hariprasad SM:

Thirty Year Follow-Up of an African-American Family With North Carolina Macular Dystrophy. Presented at The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2010.

27. Hariprasad SM, Morse LS: Delayed 15-letter Responders to Ranibizumab Treatment of

Neovascular Age-Related Macular Degeneration (AMD) in MARINA, ANCHOR, PIER, and SAILOR. Presented at the American Society of Retina Specialists Meeting, Vancouver, BC, August 29, 2010.

28. Singh A, Hariprasad SM: Polyethylene Glycol (PEG) Hydrogel Polymer Sealant for

Closure of Sclerotomies: A Variable Intraocular Pressure (IOP) and Histologic Study. Presented at the American Society of Retina Specialists Meeting, Vancouver, BC, August 30, 2010.

29. Hariprasad SM, Singh A: Polyethylene Glycol (PEG) Hydrogel Polymer Sealant for

Closure of Sclerotomies: A Variable Intraocular Pressure (IOP) and Histologic Study. Presented at The Retina Society 43rd Annual Scientific Meeting, San Francisco, CA, September 24, 2010.

30. Patelli F, Hariprasad SM, Giacomotti E, Radice P, Vergani S: Polyethylene Glycol (PEG) Hydrogel Polymer Sealant for Sclerotomy Closure: Preliminary in Vivo Clinical Results. Presented at the American Society of Retina Specialists Meeting, Boston, MA, August 22, 2011.

31. Patel RD, Hariprasad SM: Examining Recalcitrant Diabetic Macular Edema with Optos Wide-Field Fluorescein Angiography. Presented at the American Society of Retina Specialists Meeting, Boston, MA, August 23, 2011.

32. Smit L, Ardelt A, Lesniak M, Hariprasad SM, Afshar A, Cueva W: A Case of Terson’s

Syndrome Status-Post High Volume Lumbar Puncture. Presented at the 64th American Academy of Neurology Annual Meeting, New Orleans, LA, April 21, 2012.

33. Hariprasad SM, Singh A, Patelli F: Polyethylene Glycol (PEG) Hydrogel Polymer Sealant for Closure of 20g and 23g Sclerotomies- A Variable Intraocular Pressure (IOP)

Seenu M. Hariprasad

26

and Histologic Study. Presented at The Macula Society 35th Annual Scientific Meeting, Jerusalem, Israel, June 15, 2012.

34. Ranadive AA, Arora VM, Shapiro MI, Constantine K, Mayo AM, Hougham G,

Hariprasad SM, Meltzer DO, Press VG. Assessing and Correcting Vision among Hospitalized Patients: An under-recognized risk for older patients. Midwest Society of General Internal Medicine Annual Meeting, Chicago, IL September 2012.

35. Hariprasad SM, Afshar A, Fernandes J, Patel R, Ksiazek S: Cystoid Macular Edema

Associated with Fingolimod (Gilenya) 0.5mg Use for Multiple Sclerosis. Presented at The Retina Society 45th Annual Scientific Meeting, Washington, DC, October 5, 2012.

36. Patel R, Hariprasad SM: Ultra-Widefield Fluorescein Angiography Characteristics of

Recalcitrant Diabetic Macular Edema. Presented at The Retina Society 45th Annual Scientific Meeting, Washington, DC, October 5, 2012.

37. Moshfeghi D, Hariprasad SM, Marx J, Heier J: Fluid Status at Week 12 and its

Correlation with Fluid Status at Week 52 Following Intravitreal Aflibercept Injections (IAI) in the VIEW Study of wAMD Patients. Presented at The Macula Society 36th Annual Scientific Meeting, Dana Point, CA, February 28, 2013.

38. Hariprasad SM, Moshfeghi D, Marx J, Heier J: Association Between Retinal Fluid Status

at Weeks 12 and 52 in Wet-AMD Patients Treated with Intravitreal Aflibercept Injection in the VIEW Studies. Presented at the American Society of Retina Specialists Meeting, Toronto, Canada, August 25, 2013.


Associated with Fingolimod (Gilenya) 0.5mg Use for Multiple Sclerosis. Presented at The OIC WAVE 3rd Annual Scientific Meeting, Vail, CO, June 26, 2014.


Associated with Fingolimod (Gilenya) 0.5mg Use for Multiple Sclerosis. Presented at The Club Vit 17th Annual Scientific Meeting, Beaver Creek, CO, July 1, 2014.

41. Hariprasad SM, Afshar A: Cystoid Macular Edema Associated with Fingolimod

(Gilenya) 0.5mg Use for Multiple Sclerosis. Presented at The Macula Society 38th Annual Scientific Meeting, Scottsdale, AZ, February 27, 2015.

Book Chapters: 1. Grunwald JE, Piltz J, Hariprasad SM, DuPont J. Optic Nerve Blood Flow and Visual Function in Glaucoma. Ocular Blood Flow in Glaucoma. Ed. Pillunat L. Netherlands: Kugler and Ghedini, 1999.

2. Hariprasad SM, Mieler WF. Background & General Considerations-Epidemiology. AAO Ocular Trauma Monograph: Chapter 2. Eds. Mieler WF, Hairston RJ, Parver LM. San Francisco: The Foundation of the American Academy of Ophthalmology, 2003.

3. Morris R, Moore TJ, Hariprasad SM, Mieler WF. Posterior Segment Injury: Closed- Globe Trauma. AAO Ocular Trauma Monograph: Chapter 14. Eds. Mieler WF, Hairston

Seenu M. Hariprasad

27

RJ, Parver LM. San Francisco: The Foundation of the American Academy of Ophthalmology, 2003. 4. Hariprasad SM, Mieler WF. New Developments in the Treatment of Endophthalmitis. To

The Macula and Beyond. Ed. Battle IR. Netherlands: Kugler Publications, 2005.

5. Hariprasad SM, Mieler WF. Evidence-Based Medicine and the Treatment of Endophthalmitis. Evidence-Based Eye Care. Eds. Kertes PJ, Johnson TM. Lippincott Williams & Wilkins, 2007.

6. Hariprasad SM, Borrillo L, Mieler WF. Epidemiology and Prevention of Ocular Trauma.

Principles and Practice of Ophthalmology: Chapter 379. Eds. Albert DM, Miller J. 3rd Edition, W.B. Saunders Company, Philadelphia, PA, 2007.

7. Benevento JD, Kaplan BL, Hariprasad SM. Evolution of Fluorescein and Indocyanine

Green Angiography. Fundus Fluorescein and Indocyanine Green Angiography- A Textbook and Atlas: Chapter 1. Ed. Agarwal A. Slack Incorporated, Thorofare, NJ, 2008.

8. Hariprasad SM, Mieler WF. Antibiotics. Retinal Pharmacotherapy: Chapter 45. Eds.

Nguyen QD, Rodrigues EB, Farah ME, Mieler WF. Saunders Elsevier, 2010.

9. Gabrielian A, Hariprasad SM. Perfluorocarbon Liquids and Vitreoretinal Surgery: Chapter 9. Vitreoretinal Surgery. Eds. Saxena S, Meyer CH, Ohji M, Akudman L. Jaypee-Highlights Medical Publishers, 94-100, 2012.

10. Hariprasad SM, Mieler WF. Evidence-Based Medicine- The Prophylaxis and Treatment

of Endophthalmitis: Chapter 11. Evidence-Based Eye Care, 2e. Eds. Kertes PJ, Johnson TM. Lippincott Williams & Wilkins, 277-293, 2013.

Editorships: 1. Section Editor, Ocular Trauma, in Albert DM, Miller J, eds., Principles and Practice of Ophthalmology, 3rd Edition, W.B. Saunders Company, Philadelphia, PA, 2007. 2. Section Editor, Retina and Vitreous, in Chern KC, Saidel M, eds., Ophthalmology

Review Manual, 2nd Edition, Lippincott Williams & Wilkins, 2011. 3. Editor-In-Chief, Hariprasad SM ed., Management of Retinal Vein Occlusion: Current

Concepts, Slack Incorporated, Thorofare, NJ, 2014.

Invited Lecturer United States: Advanced Vitreoretinal Techniques & Technology, Chicago, IL August 2005

• “The Use of Triamcinolone Acetonide as an Adjunct in Vitreous Surgery” • “Vitreous Penetration of Orally-Administered Fourth Generation Fluoroquinolones” • “Aqueous Vitreous Penetration of Topically-Administered Moxifloxacin” • “Complications of Intravitreal Injections: Limiting the Risks”

Seenu M. Hariprasad

28

17TH Annual Midwest Ocular Angiography Conference (MOAC), Whistler, British Columbia, Canada August 2005

• “Deferoxamine Mesylate Maculopathy” Dulaney Foundation Complementary Ophthalmic Residents Education (CORE), Chicago, IL May 2006

• “NSAIDS”

University of Chicago Department of Ophthalmology Alumni Day, Chicago, IL June 2006

• “Diabetic Macular Edema- Past, Present and Future” Advanced Vitreoretinal Techniques & Technology, Chicago, IL August 19-20, 2006

• “Diabetic Macular Edema: Past, Present, and Future” • “The Role of Triamcinolone and Indocyanine Green as Surgical Adjuncts” • “Risk Factors and Prevention of Age-Related Macular Degeneration (AREDS II)”

18th Annual Midwest Ocular Angiography Conference (MOAC), Girdwood, Alaska August 2-5, 2006

• “New Generation NSAIDS” • “Central Retinal Artery and Vein Occlusions Secondary to Patent Foramen Ovale”

Annual Chicago Curriculum in Ophthalmology Lecture Series, University of Illinois, Chicago, IL September 21, 2006

• “Endophthalmitis” Illinois Optometric Association Meeting, Springfield, IL September 30, 2006

• Retina Disease Panel: “Clinical Trials and Novel Treatment Strategies for Macular Degeneration and Diabetic Macular Edema”

University of Louisville: Eye Specialists of Louisville, Louisville, KY January 19, 2007

• Chief Resident Grand Rounds: “An Update on Age-Related Macular Degeneration” Saint Vincent Catholic Hospital and Medical Center: Department of Ophthalmology, New York, NY March 7, 2007

• Grand Rounds: “Advances in Endophthalmitis Management” Illinois College of Optometry, Chicago, IL March 17, 2007

• Retina Disease Panel: “Diabetic Macular Edema: Past, Present, Future” University of Nebraska Medical Center: Department of Ophthalmology, Omaha, NE March 23, 2007

• Grand Rounds: “Combination Therapy for Exudative Age-Related Macular Degeneration”

Seenu M. Hariprasad

29

Collaborative Network of Innovative Vitreoretinal Specialists (CONNECT Network): Orlando, FL March 31, 2007

• “The Use of New Generation NSAIDS for the Treatment of Cystoid Macular Edema”

West Virginia University: Department of Ophthalmology, Morgantown, WV May 3, 2007

• Grand Rounds: “An Update on Age-Related Macular Degeneration” University of Chicago Department of Ophthalmology Alumni Day, Chicago, IL June 16, 2007

• “Intraoperative Use of Triamcinolone Acetonide” Austin Ophthalmological Society, Austin, TX August 9, 2007

• “An Update on Age-Related Macular Degeneration”

Advanced Vitreoretinal Techniques & Technology, Chicago, IL September 7-9, 2007

• Moderator: Vitreoretinal Surgical Techniques “Discussion of Small Incision Vitrectomy Surgery”

• “Treatment Algorithm of Diabetic Macular Edema” • “The Use of Surgical Adjuncts (Triamcinolone, Indocyanine Green, Trypan Blue)” • “Prevention of Exudative AMD (AREDS I, AREDS II, CAPT)” • “Expanding Role of Topical Non-Steroidal Inflammatory Agents”

Northern Virginia Ophthalmological Society, Falls Church, VA September 10, 2007

• “Diabetic Macular Edema: Past, Present, and Future” • “The New Generation NSAIDS: A Focus on Cystoid Macular Edema”

Erie Ophthalmological Society, Erie, PA October 11, 2007


Lehigh Valley Ophthalmological Society, Bethlehem, PA November 1, 2007

• “Diabetic Macular Edema: Past, Present, and Future” • “An Update on Non-Steroidal Anti-Inflammatory Agents”

Advanced Vitreoretinal Techniques & Technology, New Orleans, LA November 10, 2007

• “Maximizing Surgical Outcomes: The Role of the New Generation NSAIDS in Treating Cystoid Macular Edema”

American Society of Retina Specialists, Palm Springs, CA December 2, 2007

• Moderator: Symposium 3- Age Related Macular Degeneration Florida Optometric Association, Gainesville, FL

Seenu M. Hariprasad

30

December 6, 2007 • “An Update on Age-Related Macular Degeneration”

East Bay Ophthalmological Society, Oakland, CA February 6, 2008


Peninsula Eye Society, San Francisco, CA February 7, 2008


20th Annual Midwest Ocular Angiography Conference (MOAC), Lake Louise, Canada August 6-9, 2008

• “North Carolina Dystrophy in African American Family” • “Branch Retinal Vein Occlusion and Optic Neuropathy in Scleroderma”

Advanced Vitreoretinal Techniques & Technology, Chicago, IL August 22-24, 2008

• “VEGF Trap and other Forthcoming Treatment Options for Wet AMD” • “Treatment Algorithm of Diabetic Macular Edema” • “The Use of Corticosteroids and Vital Dyes in Vitreoretinal Surgery- Are they Essential

or Potentially Harmful?” • “Risk Factors and Prevention of Exudative AMD (AREDS I & AREDS II)” • “Treatment and Prevention of Postoperative Cystoid Macular Edema”

Tampa Bay Ophthalmic Society Meeting, Tampa, FL August 28, 2008


Volusia County Ophthalmology Society Meeting, Daytona Beach, FL September 2, 2008


Lexington Ophthalmology Society, Lexington, KY November 18, 2008


Illinois Eye Institute, Chicago, IL December 5, 2008

• Grand Rounds: “Age Related Macular Degeneration: Pathophysiology and Focus on Current and Future Treatment Strategies”

Vitreo-Retinal Consultants & Surgeons, Wichita, KS May 18, 2009

Seenu M. Hariprasad

31

• Annual Continuing Medical Education Guest Lecture “Age Related Macular Degeneration: Pathophysiology and Focus on Current and Future Treatment Strategies”

Broward County Ophthalmological Society, Fort Lauderdale, FL July 15, 2009


Georgia Society of Ophthalmology, Amelia Island, FL July 17-19, 2009

• Annual Continuing Medical Education Meeting Invited Lecturer • “Diabetic Macular Edema: Past, Present, and Future” • “The New Generation NSAIDS: A Focus on Cystoid Macular Edema”

CONNECT Network Live CME Accredited Webinar Series, Chicago, IL July 23, 2009

• “Evolving Trends for Managing and Treating Age Related Macular Degeneration Utilizing New Generation Retinal Imaging”

CONNECT Network Live CME Accredited Webinar Series, Chicago, IL

August 27, 2009 • “Evolving Trends in the Dosing of Anti-VEGF Therapy for Exudative Age Related

Macular Degeneration” North Dakota Society of Eye Physicians and Surgeons, Bismarck, ND September 25, 2009

• Annual Continuing Medical Education Meeting Invited Lecturer • “Diabetic Macular Edema: Past, Present, and Future” • “The New Generation NSAIDS: A Focus on Cystoid Macular Edema”

Delaware Academy of Ophthalmology, Wilmington, DE October 8, 2009

• Bi-annual Continuing Medical Education Meeting Invited Lecturer • “Diabetic Macular Edema: Past, Present, and Future” • “The New Generation NSAIDS: A Focus on Cystoid Macular Edema”

Joint Meeting of the American Academy of Ophthalmology and the Pan-American Association of Ophthalmology Editors’ Choice Symposium, San Francisco, CA October 27, 2009

• Invited Discussant • “Randomized Trial to Compare the Efficacy and Safety of Intravitreal Injections of

Triamcinolone Acetonide with Observation to Treat Vision Loss Associated with Macular Edema Secondary to Central Retinal Vein Occlusion: The SCORE-CRVO Trial”

The National Retina Institute Complementary Ophthalmic Residents Education (CORE), Chicago, IL November 14-15, 2009

• “Vitreous Loss- What now?” New York Eye and Ear Infirmary, New York, NY November 17, 2009

Seenu M. Hariprasad

32

• Chief Resident Grand Rounds Invited Lecturer • “Update on the Management of Macular Edema Secondary to Retinal Vein Occlusion”

SUNY Downstate Medical Center Department of Ophthalmology: Current Concepts in Ophthalmology 2010, Atlantic City, NJ January 8-9, 2010

• Continuing Medical Education Meeting Invited Moderator: Retina/Uveitis Subsection Hackensack University Medical Center, Hackensack, NJ January 19, 2010

• Continuing Medical Education Meeting Grand Rounds Invited Lecturer • “Diabetic Macular Edema: Past, Present, and Future” • “Case Report: Bilateral Choroiditis from Prototheca Wickerhamii Algaemia ” • “Fungal Eye Disease: A Focus on the New Generation Triazoles”

ALTA Ophthalmological Society, Sacramento, CA January 21, 2010

• Continuing Medical Education Meeting Invited Lecturer • “Diabetic Macular Edema: Past, Present, and Future” • “The New Generation NSAIDS: A Focus on Cystoid Macular Edema”

Review of Ophthalmology CME Series: Advances in Retinal Vein Occlusion January-April, 2010

• Invited Moderator: Cleveland, Minneapolis, Dallas, and Detroit

Ventura Eye Society, Ventura, CA April 22, 2010

• Quarterly Continuing Medical Education Meeting Invited Lecturer • “Diabetic Macular Edema: Past, Present, and Future” • “The New Generation NSAIDS: A Focus on Cystoid Macular Edema”

The Association for Research in Vision and Ophthalmology 2010, Ft. Lauderdale, FL May 3, 2010

• Invited Co-Moderator with Neil Bressler, M.D. • Session: Age Related Macular Degeneration- Clinical Trials II

Vitreoretinal Technology and Techniques Update 2010-2011 CME Series May, 2010-August, 2011

• Course Moderator • Ft. Lauderdale, Indianapolis, Kansas City, Milwaukee, Detroit, New York City,

Philadelphia, San Francisco, Dallas, and Grand Rapids Ocular Inflammation: A Peer to Peer Discussion CME Program, Buffalo, NY May 27, 2010

• Invited Moderator • “Ocular Inflammation- Evaluating the Current Standard of Care”

Illinois Eye Institute: New Paradigms in Age-Related Retinal Disease, Chicago, IL June 13, 2010

Seenu M. Hariprasad

33

• Invited Speaker • “Age Related Macular Degeneration: Pathophysiology and Focus on Current and Future

Treatment Strategies”

Advanced Vitreoretinal Techniques & Technology, Chicago, IL September 10-12, 2010

• “Diabetic Macular Edema: Past, Present and Future” • “Use of Intraoperative Surgical Stains/Dyes and Corticosteroids”

University of Buffalo Department of Ophthalmology: Ross Eye Center, Buffalo, NY November 23, 2010

• Continuing Medical Education Meeting Grand Rounds Invited Lecturer • “Diabetic Macular Edema: Past, Present, and Future”

Loyola University Stritch School of Medicine Department of Ophthalmology, Chicago, IL February 16, 2011

• Continuing Medical Education Meeting Grand Rounds Invited Lecturer • “Diabetic Macular Edema: Past, Present, and Future”

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine: Vitreoretinal Surgery- Fundamentals and Pearls, Palm Beach Gardens, FL March 13, 2011

• Continuing Medical Education Meeting Invited Guest Lecturer • “Use of Intraoperative Vital Dyes and Corticosteroids”

The Association for Research in Vision and Ophthalmology 2011, Ft. Lauderdale, FL May 4, 2011

• Invited Co-Moderator with Rishi Singh, M.D. • Session: Macular Edema

Chicagoland Midwest Retina Update, Chicago, IL May 21, 2011

• Continuing Medical Education Meeting Invited Guest Lecturer • “Use of Steroids and Vital Dyes in Vitrectomy Surgery” • Panel Participant: Medical and Surgical Vitreoretinal Cases

Tucson Ophthalmological Society, Tucson, AZ May 26, 2011

• “Emerging Concepts in the Treatment of Macular Edema Following Retinal Vein Occlusion”

CONNECT Network CME Accredited Educational Series May 1, 2012

• Course Director • “Advances in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion” • Fifteen nationwide CME programs conducted by the CONNECT Network Members

Des Moines Ophthalmic Society, Des Moines, IA February 9, 2012

Seenu M. Hariprasad

34

• “The Use of New-Generation Corticosteroids in the Treatment of Ocular Inflammation and Macular Edema”

Chicagoland Midwest Retina Update 2nd Annual Meeting, Chicago, IL May 18, 2012

• Continuing Medical Education Meeting Invited Guest Lecturer • “Use of Dyes in Vitreoretinal Surgery” • “Current Trends in the Management of Post Operative Endophthalmitis: Do the EVS

Recommendations Still Apply?” • Panel Participant: Medical and Surgical Vitreoretinal Cases

University of Rochester Department of Ophthalmology, Rochester, NY May 25, 2012

• Retina Grand Rounds • “Age-Related Macular Degeneration”

Evolving Management of Vitreoretinal Diseases: Focus on the Use of Anti-VEGF for the Treatment of Wet AMD July-December, 2012

• Course Director • CME Accredited Educational Series

Tampa Bay Ophthalmic Society Meeting, Tampa, FL October 30, 2012

• “Advances in the Management of Macular Edema Secondary to Retinal Vein Occlusion” Evolving Management of Vitreoretinal Diseases: Focus on the Use of Anti-VEGF for the Treatment of Wet AMD and Retinal Vein Occlusions March-May, 2013

• Course Director • CME Accredited Educational Series conducted by the CONNECT Network

ALTA Ophthalmological Society, Sacramento, CA April 16, 2013

• Invited Lecturer • “Corticosteroids for the Management of Macular Edema Secondary to Retinal Vein

Occlusion”

Confronting Uveitis & Postoperative Inflammation: Challenges in Diagnosis and Treatment, New Orleans, LA November 16, 2013

• Course Director • “Uveitis Clinical Trials: A Review of FDA-approved Therapies” • CME Accredited Educational Program

Rabb Citywide Retina Study Club, Chicago, IL February 26, 2014

• Course Director

Chicagoland Midwest Retina Update 4th Annual Meeting, Chicago, IL

Seenu M. Hariprasad

35

May 16, 2014 • Continuing Medical Education Meeting Invited Guest Lecturer • “Use of Steroids & Dyes in Vitreoretinal Surgery: Are they Essential or Potentially

Harmful?” • “Current Trends in the Management of Post Operative Endophthalmitis: Do the EVS

Recommendations Still Apply?” • Panel Participant: Medical Retina

Frontiers of Medical Retina 2014: Clinical Decision Making in Retinal Pharmacotherapy, St. Louis, MO May 31, 2014

• Invited Lecturer • “What’s New in the Treatment of Diabetic Macular Edema” • CME Accredited Educational Program

OIC WAVE 3rd Annual Scientific Meeting, Vail, CO

June 27, 2014 • Invited Panel Participant: Branch Retinal Vein Occlusion

Integrated Cross-Disciplinary Approaches to the Management of Diabetic Eye Diseases June-November, 2014

• Course Director • San Francisco, Chicago, Detroit, Philadelphia, Miami • CME Accredited Educational Series

American Academy of Ophthalmology Annual Meeting- Retina Subspecialty Day, Chicago, IL October 17, 2014

• Invited Panel Participant • Retinal Vein Occlusions: Brown DM, Hariprasad SM, Fekrat S, Kunimoto DY, Olsen

TW, Scott IU, Tufail Adnan •

Palm Beach Ophthalmic Society Meeting, Palm Beach, FL October 23, 2014

• “Advances in the Management of Diabetic Macular Edema- Clinical Trial Overview”

Diabetic Eye Disease: Evolving Treatment Paradigms, Chicago, IL November 8, 2014

• Invited Lecturer • “Anti-VEGF Therapy for Diabetic Macular Edema” • “Management of Proliferative Diabetic Retinopathy” • CME Accredited Educational Program

Rabb Citywide Retina Study Club, Chicago, IL February 18, 2015

• Course Director

Invited Lecturer International: University of Illinois College of Medicine Ophthalmology Update “From Front to Back”, Riviera Maya, Mexico

Seenu M. Hariprasad

36

February 15, 2006 • “Penetration Pharmacokinetics of Orally Administered 4th Generation Fluoroquinolones

in Humans”

XV Annual Conference of Vitreoretinal Society of India, Cochin, Kerala December 8, 2006

• Keynote Speaker • “VEGF Trap” • “Expanding Treatment Options for Endophthalmitis”

Sunayana 2007: The 65th Annual Meeting of the All India Ophthalmological Society, Hyderabad, India February 1-4, 2007

• Keynote Speaker • Keynote Address: “Elimination of Pre-Operative Conjunctival Bacterial Flora with the

use of Mupirocin Nasal Ointment” • “A Phase 1 Safety, Tolerability, and Bioactivity Study of Intravitreal VEGF Trap in

Patients With Neovascular AMD: The CLEAR-IT Study” • Retina Seminar: Paradigm Shift in the Treatment of AMD. “Risk Factors and Prevention

of Age-Related Macular Degeneration (AREDS I-AREDS II-CAPT)” • Retina Seminar: Advances in Age Related Macular Degeneration. “Insights with

Lucentis: From clinical trials to clinical practice” EYEINFO 2008: The 66th Annual Meeting of the All India Ophthalmological Society, Bangalore, India February 1-4, 2008

• Keynote Speaker • Keynote Address: “Expanding Treatment Options for Endophthalmitis” • “Endophthalmitis and Intravitreal Injections- Minimizing the Risk” • “Cataract Surgery and the Acceleration of Age Related Macular Degeneration- The Role

of the Blue Light Filtering IOL’s” • Retina Seminar: “Ranibizumab Update- MARINA and ANCHOR Review with Subgroup

Analysis” • Retina Seminar: “AMD Future Directions II- The VEGF-Trap”

Vitreoretinal Society of India National Symposium at AIOS, Bangalore, India February 2, 2008

• “VEGF Trap for Neovascular Age-Related Macular Degeneration”

Madras City Ophthalmological Society, Chennai, India January 31, 2009

• “Cystoid Macular Edema: Newer Concepts and its Management” The 67th Annual Meeting of the All India Ophthalmological Society, Jaipur, India February 5-8, 2009

• Keynote Speaker • Foreign Faculty Guest Oration: “VEGF Trap” • “Role of New Generation NSAIDS in Preventing Cystoid Macular Edema after Cataract

Surgery”

12th Vitreoretinal Symposium Frankfurt – Marburg 2009, Frankfurt/Main, Germany

Seenu M. Hariprasad

37

August 27-29, 2009 • Invited Lecturer • Chairman and Moderator: The Upcoming in Vitreretinal Surgery • “Retina Lasers: Past, Present, and Future” • “Current Shortcomings on Photocoagulation”

World Ophthalmology Conference 2010, Berlin, Germany June 7, 2010

• Symposium Invited Lecturer: The Patient’s Perspective on Diabetic Macular Edema- Maximizing Quality of Life in the Management of DME

• Keynote Lecture: Evaluating the Whole Patient- Diabetic Macular Edema, Quality of Life, and Associated Co-morbidities

Dubai Health Authority (Dubai Hospital) Continuing Medical Education Program, Dubai, UAE April 16, 2011

• “Current Concepts in the Management of Macular Edema” Ranchi Ophthalmological Society, Ranchi, India November 23, 2011

• “Current Concepts in the Management of Macular Edema”

Bombay Ophthalmologists’ Society, Mumbai, India November 26, 2011

• “Current Concepts in the Management of Macular Edema” Madras City Ophthalmological Society, Chennai, India November 27, 2011

• “Current Concepts in the Management of Macular Edema”

VI Asia-Pacific Vitreoretinal Society Congress (APVRS) held in conjunction with the XX Annual Conference of Vitreoretinal Society of India, Hyderabad, India December 1-3, 2011

• Keynote Speaker • “Emerging Concepts in Wide-Field Imaging for Vitreoretinal Disease” • “VEGF Trap” • “The Uncharted Realm of Ultra Wide-Field Imaging for Vitreoretinal Diseases”

5th Congress of the Panamerican Vitreoretinal Society and XIV GLADAOF Forum, San Jose, Costa Rica May 16-19, 2012

• Invited Speaker • “Combined Ophthalmic Artery and Central Retinal Vein Occlusion secondary to Patent

Foramen Ovale” • “VIEW Studies: Clinical Results in Wet AMD”

Sociedad Panamericana de Retina y Vitreo, Buenos Aires, Argentina

November 29-30, 2012 • Invited Speaker • “Current Landscape of Wet Age-Related Macular Degeneration”

Seenu M. Hariprasad

38

• “Trials Comparing Monthly and Every Other Month Treatment for Exudative Age-Related Macular Degeneration”

Augenarztliche Akademie Deutschland (Ophthalmological Academy of Germany), Dusseldorf, Germany March 2, 2013

• Invited Speaker • “Aflibercept for the Treatment of Wet Age-Related Macular Degeneration: The US

Experience” World Ophthalmology Conference 2014, Tokyo, Japan April 4, 2014

• Symposium Invited Lecturer: Ultra-Widefield Retinal Imaging- A New Standard of Care • “The Role of Ultra-widefield Imaging in Diabetic Retinopathy and Macular Edema”

Asia Pacific Academy of Ophthalmology Session at World Ophthalmology Conference, Tokyo, Japan April 4, 2014

• Symposium Invited Lecturer: Diabetic Macular Edema • “Role of Ultra Wide Field Imaging in Diabetic Macular Edema”

Selçuk University, Konya, Turkey May 21, 2015

• Invited Grand Rounds Keynote Lecturer • “Comparative Effectiveness Study of Aflibercept, Bevacizumab, or Ranibizumab for

DME: DRCR Protocol T”

38th Bahar Sempozyumu (38th Annual Turkish Ophthalmological Society Meeting), Istanbul, Turkey May 22-24, 2015

• Symposium Invited Lecturer: Diabetic Macular Edema • “Diabetic Macular Edema: Past, Present, and Future” • “Comparative Effectiveness Study of Aflibercept, Bevacizumab, or Ranibizumab for

DME: DRCR Protocol T” Press, Television, Radio Interviews: October 4, 2006 – WGN Channel 9 (Nationwide network television broadcast) discussing novel

new treatments for exudative Age-Related Macular Degeneration. October 4, 2006 – CBS Channel 2 (Chicago television broadcast) discussing novel new treatments

for exudative Age-Related Macular Degeneration. AMD Awareness Week: Radio Interviews with Dr. Hariprasad and his patient Mr. Kenneth Recu September 23, 2008 – WCCI-FM (Springfield, IL)

September 23, 2008 – WDIS-AM (Boston, MA) September 23, 2008 – WDUK-AM (Havana, IL) September 23, 2008 – WLPO-AM (Chicago, IL) October 3, 2008 – WCSM-AM (Dayton, OH) October 3, 2008 – WBSM-AM (Providence, RI) October 3, 2008 – WCSR-AM (Flint, MI)

Seenu M. Hariprasad

39

August 2009, Volume 7, Issue 5 – Chicago Hospital News “Latest Eye Care Available at Weiss” (Highlight of Dr. Hariprasad and Vitreoretinal Services offered at Weiss Memorial Hospital) July 2012 – Healthy Living Made Simple by Sam’s Club “Vitamin See: 6 Important Nutrients for Healthy Eyes”, Page 47 February 5, 2013 – “University of Chicago Medicine is the First in Illinois to Adopt TrueVision 3D Surgical System for Ophthalmic Surgery and Teaching” -The Daily Herald -The San Francisco Chronicle -The Miami Herald -The Cincinnati Enquirer -LA Daily News -CBS Money Watch -The Boston Globe

Medical and Scientific Experience: 1. C&S Computers- Hornell, NY / Philadelphia, PA

• 1992-1999 • Designed custom software packages and databases for specific medical applications • IBM computer sales, support, and service • President & Founder

2. Collaborative Network of Innovative Vitreoretinal Specialists Network (CONNECT Network)

• 2006-present • Founder • Website: www.retinaconnect.org

3. Collaborative Network of Innovative Vitreoretinal Specialists Network (CONNECT Network) • 2006-present • Board President of CONNECT Non-Profit Organization

4. Pfizer Visiting Professorships in Ophthalmology

• 2007-2009 • Board Member serving to determine allocation of grant funds from Pfizer’s Medical and

Academic Partnerships programs to support Visiting Professorships in Ophthalmology

5. Medical Advisor, Ocular Therapeutix • 2008-2013 • A Prospective, Randomized, Multi-Center, Parallel Arm Study to Evaluate the Safety and

Performance of the I-ZIP® Ocular Bandage Compared With the OASIS 24-Hour Soft Shield Collagen Corneal Shield for Providing Ocular Protection and Relief of Pain/Discomfort in Subjects Undergoing Clear Corneal Cataract Surgery

6. Medical Advisor, Clearside Biomedical • 2013-present

Industry / Government Sponsored Research:

Seenu M. Hariprasad

40

1. Bristol-Myers Squibb Company Clinical Research Grant, Principal Investigator, Vitreous and

Aqueous Penetration of Orally Administered Gatifloxacin in Humans, Cullen Eye Institute- Baylor College of Medicine, Houston, TX , 2001-2002.

2. GenVec, Inc., Sub Investigator, An Open-Label, Phase I, Single Administration, Dose-

Escalation Study of ADGVPEDF.11D (Pigment Epithelial Derived Factor) in Neovascular ARMD, Cullen Eye Institute- Baylor College of Medicine, Houston, TX , 2002-2003.

3. GenVec, Inc., Sub Investigator, Evaluation of the Effects of ADGVPEDF.11D (Pigment

Epithelial Derived Factor) In Neovascular ARMD using Optical Coherence Tomography, Cullen Eye Institute- Baylor College of Medicine, Houston, TX , 2002-2003.

4. Genentech, Inc., Sub Investigator, Phase III, Multicenter, Randomized, Double-Masked

Study of the Efficacy and Safety of rhuFab V2 in Subjects with Minimally Classic or Occult Subfoveal Neovascular ARMD (MARINA), 2003.

5. Genentech, Inc., Sub Investigator, Phase III, Multicenter, Randomized, Double-Masked

Study of the Efficacy and Safety of rhuFab V2 Compared with Visudyne in Subjects with Predominantly Classic Subfoveal Neovascular ARMD (ANCHOR), 2003.

6. Alcon, Inc., Sub Investigator, An Evaluation of Efficacy and Safety of Posterior Juxtascleral

Administrations of Anacortave Acetate for Depot Suspension versus Sham Administration in Patients at Risk for Developing CNV due to Exudative Age Related Macular Degeneration Barnes Retina Institute- Washington University School of Medicine, St. Louis, MO, 2004.

7. Regeneron Pharmaceuticals, Inc., Principal Investigator, An Exploratory Study of the Safety,

Tolerability, and Biological Activity of Intravenously Administered VEGF Trap in Patients with Diabetic Macular Edema Barnes Retina Institute- Washington University School of Medicine, St. Louis, MO, February 2004.

8. Bayer Pharmaceutical Clinical Research Grant, Principal Investigator, Vitreous and Aqueous

Penetration of Orally Administered Moxifloxacin in Humans Barnes Retina Institute- Washington University School of Medicine, St. Louis, MO, 2004.

9. Regeneron, Principal Investigator, An Exploratory Study of the Safety, Tolerability and

Biological Effect of Intravitreal Administration of VEGF Trap in Patients with Neovascular Age-Related Macular Degeneration (VGFT-OD-0502), 2005-2008.

10. Allergan, Principal Investigator, DME, A 3-Year, Phase 3, Multicenter, Masked,

Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700µg and 350µg Dexamethasone Posterior Segment Drug Delivery System (Dex PS DDS) Applicator System in the Treatment of Patients with Diabetic Macular Edema), 2005-2010.

11. Alimera Sciences, Principal Investigator, A Randomized, Double-Masked, Parallel Group,

Multi-Center, Dose-Finding Comparison of the Safety and Efficacy of ASI-001A 0.5 µg/day and ASI-001B 0.2 µg/day Fluocinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects With Diabetic Macular Edema, 2005-2009.

12. Othera Pharmaceuticals, Sub-Investigator, A Multi-Center, Double-Masked, Randomized,

Vehicle-Controlled, Parallel Group Evaluation of the Safety and Efficacy of OT-551

Seenu M. Hariprasad

41

Ophthalmic Solution to Prevent Formation or Delay Progression of Nuclear Cataract Formulation in Post-Vitrectomy Patients, 2005-2007.

13. Genaera Pharmaceuticals, Sub-Investigator, A Phase 3 Multicenter, Randomized, Double-

Masked, Controlled Study of Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated with Age-Related Macular Degeneration, 2005-2007.

14. Novartis Pharmaceuticals, Sub-Investigator, A Randomized, Double-masked, Multicenter,

Phase I/II Study of the Safety of PTK787 Administered in Conjunction With Photodynamic Therapy With Visudyne to Patients With Predominantly Classic, Minimally Classic or Occult With No Classic Subfoveal CNV Secondary to ARMD, 2005-2007.

15. Acuity Pharmaceuticals, Sub-Investigator, A Phase II, Randomized, Double-Masked,

Controlled, Dose Comparison Study of Cand5 for Intravitreal Injection for the Treatment of Subfoveal CNV Associated with Wet ARMD, 2005-2007.

16. Allergan, Principal Investigator, A Six-months, Phase III, Multicenter, Randomized, Sham-

Controlled Trial (With Six-months Open-Label Extension) to Assess the Safety and Efficacy of 700 ul and 350 ug Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS Applicator System) in the Treatment of Patients with Macular Edema Following Central Retinal Vein Occlusion or Branch Retinal Vein Occlusion, 2005-2009.

17. NIH/NEI, Principal Investigator, The SCORE Study: A Randomized Trial to Compare the

Efficacy and Safety of Intravitreal Injection(s) of Triamcinolone Acetonide with Standard Care to Treat Macular Edema Associated With Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion, 2005-2009.

18. NIH/NEI, Sub-Investigator, Diabetic Retinopathy Clinical Research Network: A

Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema, 2005-2007.

19. Eyetech Pharmaceuticals, Sub-Investigator, A Phase 2/3 Randomized, Controlled, Double-

Masked, Multi-Center, Comparative Dose-Finding Trial, in Parallel Groups, to Compare the Safety and Efficacy of Intravitreous Injections of 0.3, 0.03 or 0.003 mg Pegaptanib Sodium (Macugen), Given as Often as Every 6 Weeks for 3 years, to Sham Injections, in Subjects with Diabetic Macular Edema (DME) Involving the Center of the Macula, 2005-2007.

20. Regeneron, Principal Investigator, A Randomized Controlled Study of the Safety,

Tolerability and Biological Effect of Repeated Intravitreal Administration of VEGF Trap in Patients with Neovascular Age-Related Macular Degeneration Clinical Evaluation of Anti-Angiogenesis in the Retina Intravitreal Trial AMD Phase 2 (CLEAR-IT AMD-2), 2006-2008.

21. Alcon Pharmaceuticals, Principal Investigator, Nevanac, Determination of Aqueous and

Vitreous Concentration of Topically Administered Nepafenac 0.1% (Nevanac) and Ketorolac 0.4% (Acular LS) in Humans, 2006-2007.

22. National Eye Institute, Sub Investigator, The Age-Related Eye Disease Study 2 (AREDS 2):

A Multi-center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA] in Age-Related Macular Degeneration, 2006 - 2007.

Seenu M. Hariprasad

42

23. Novartis, Principal Investigator, In Sight CNV Registry – Longitudinal Database to Capture

Patient Demographics and Treatment Outcomes in Patients with CNV due to AMD, 2006-2007.

24. National Institute of Health, Sub-Investigator, A Randomized, Placebo-Controlled, Dose-

Escalation Study to Assess the Safety and Effect of Cidofovir in Kidney Transplant Recipients with BK Virus Nephropathy, 2006-2009.

25. Alcon, Inc., Principal Investigator, An Evaluation of Efficacy and Safety of Posterior

Juxtascleral Administrations of Anacortave Acetate for Depot Suspension versus Sham Administration in Patients at Risk for Developing CNV due to Exudative Age Related Macular Degeneration, 2005-2008.

26. Genentech, Principal Investigator, A Phase III, Multicenter, Randomized, Sham Injection-

Controlled Study of the Efficacy and Safety of Ranibizumab Injection Compared With Sham in Subjects With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE), 2008-2010.

27. Genentech, Principal Investigator, A Phase III, Multicenter, Randomized, Sham Injection-

Controlled Study of the Efficacy and Safety of Ranibizumab Injection Compared With Sham in Subjects With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO), 2008-2010.

28. Pfizer, Principal Investigator, A Phase II Prospective, Randomized, Multi-Center, Diabetic

Macular Edema Dose Ranging, Comparator Study Evaluating The Efficacy and Safety of PF-04523655 Versus Laser Therapy (DEGAS), 2009-2011.

29. Genentech, Principal Investigator, An Open-Label, Multicenter Extension Study to Evaluate

the safety and tolerability of Ranibizumab in Subjects with Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD) or Macular Edema Secondary to Retinal Vein Occlusion (RVO) Who Have Completed A Genentech-Sponsored Ranibizumab Study (HORIZON), 2009-2011.

30. Glaxo Smith Kline, Principal Investigator, Pattern of Treatment for Wet AMD and Health

Outcomes of Anti-VEGF Therapy in Ophthalmic Clinics in the US: a Medical Chart Review (PRACTICE), 2009-2010.

31. Genentech, Principal Investigator, A Study of Ranibizumab Administered Monthly or on an

As-Needed Basis in Patients With Subfoveal Neovascular Age-Related Macular Degeneration (HARBOR), 2010-2012.

32. Genentech, Principal Investigator, A Study Evaluating Dosing Regimens for Treatment With

Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion (SHORE), 2011-2013

33. Fovea Pharmaceuticals, Principal Investigator, Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy, 2011-2012.

Seenu M. Hariprasad

43

34. Alimera Sciences, Principal Investigator, Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study, 2011-2014.

35. Lpath / Pfizer Pharmaceuticals, Principal Investigator, Efficacy and Safety Study of iSONEP

With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD) (Nexus), 2012-2015.

36. XOMA, Principal Investigator, Safety and Efficacy Study of Gevokizumab to Treat Active

Non-infectious Uveitis (EYEGUARD™-A), 2013-present.

37. XOMA, Principal Investigator, Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment (EYEGUARD™-C), 2013-present.

38. XOMA, Principal Investigator, An Open-label, Rollover Study Providing Continued Dosing

of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data (EYEGUARD™-E), 2014-present.

Editorial Advisory Board: American Journal of Ophthalmology, Elsevier Publications 2007-present American Academy of Ophthalmology O.N.E. Network Retina Editorial Board, 2013-present

Retinal Physician, Wolters Kluwer Health- Lippincott Williams & Wilkins VisionCare Group 2007-2012 EyeTube Ophthalmic Video Resource (www.eyetube.net), Retina Section Co-Editor, 2006-2011 Ocular Surgery News, Retina/Vitreous Section Editorial Board, Slack Incorporated 2010-present Ophthalmic Surgery, Lasers, and Imaging: Retina, Slack Incorporated 2012-present Retinal Physician, PentaVision 2013-present New Retinal Physician, PentaVision 2014-present

Scientific Referee: Archives of Ophthalmology / JAMA Ophthalmology Ophthalmology British Journal of Ophthalmology

RETINA Journal of Cataract and Refractive Surgery CORNEA Journal of Ocular Pharmacology and Therapeutics

Indian Journal of Ophthalmology EYE Acta Ophthalmologica

Teaching:

Senior Instructor American Academy of Ophthalmology “Advances in Endophthalmitis Management” – Instruction Course #633 October 2005

Seenu M. Hariprasad

44

Senior Instructor American Academy of Ophthalmology “Advances in Endophthalmitis Management” – Instruction Course #514 November 2006 Instructor American Academy of Ophthalmology “Intravitreal Pharmacotherapy: Applications in Retinal Disease” - Instruction Course #381 November 2006 Senior Instructor American Academy of Ophthalmology “Advances in Endophthalmitis Management” – Instruction Course #630 November 2007 Instructor American Academy of Ophthalmology “Intravitreal Pharmacotherapy: Applications in Retinal Disease” - Instruction Course #367 November 2007 Senior Instructor

The 66th Annual Meeting of the All India Ophthalmological Society “Advances in the Management of Age Related Macular Degeneration”

February 2008 Senior Instructor American Academy of Ophthalmology “Advances in Endophthalmitis Management” – Instruction Course #345 November 2008 Senior Instructor American Academy of Ophthalmology “Advances in Endophthalmitis Management” – Instruction Course #725 October 2009

Instructor American Academy of Ophthalmology “Peering Into the Periphery: Applications of Wide-Angle Retinal Imaging” - Instruction Course

#596 November 2013

Instructor American Academy of Ophthalmology “Peering Into the Periphery: Applications of Wide-Angle Retinal Imaging” - Instruction Course

#173 October 2014 University of Chicago Pritzker School of Medicine Summer Research Program:

2006 Loren Miller • “Vision-Related Quality of Life in Patients with Diabetic Macular Edema”

Seenu M. Hariprasad

45

2006 Vanitha Johnson • “Diabetic Retinopathy’s Impact on Vision-Related Quality of Life” • First place award for best clinical research study

2007 Greg Burell

• “Vision-Related Quality of Life in Patients following 20, 23, and 25 gauge Vitrectomy Surgery”

University of Chicago First Year Clinical Encounters (FYCE) 2009-2011 Ophthalmology Mentor Program Director, University of Chicago Department of Surgery Fellowship in the Diseases and Surgery of the Retina, Vitreous, and Macula (AUPO Certified) http://surgery.uchicago.edu/specialties/ovs/education/msgdirector/ First Endowment established 2014: Shui-Chin Lee Fellowship Endowment Fund in the Diseases and Surgery of the Retina, Macula and Vitreous Second Endowment established 2015: Snyder Family Fellowship Endowment Fund in the Diseases and Surgery of the Retina, Macula and Vitreous 2005-2007 Joseph Benevento, M.D. 2006-2008 Richard C. Lin, M.D., Ph.D. 2007-2009 Theodore Lin, M.D. 2008-2010 Veeral Sheth, M.D. 2009-2011 Paulpoj Chiranand, M.D. 2010-2012 Ravi D. Patel, M.D. 2011-2013 Shaun Ittiara, M.D. 2012-2014 Jose Garcia-Gonzalez, M.D. 2013-2015 Shawn Lewis, M.D. 2014-2016 Ankur Shah, M.D.: 1st Shui-Chin Lee Fellow in the Diseases and Surgery of the

Retina, Macula and Vitreous 2015-2017 Raj Patel, M.D.: 1st Snyder Family Fellow in the Diseases and Surgery of the

Retina, Macula and Vitreous Copyrights (U.S. Library of Congress): 1993 - Nephron©. Database for the automation of medical records and treatment histories. 1989 - The Peritoneal Dialysis Calculator©. Software for analyzing the peritoneal dialysis prescription. 1988 - The Dialysis Calculator 1.0©. Software for mathematic modeling of hemodialysis.

Hariprasad CV 7-2015 - APAO 20162016.apaophth.org/.../2015/07/Hariprasad-CV-7-2015.pdf ·...

Documents

Transcript of Hariprasad CV 7-2015 - APAO 20162016.apaophth.org/.../2015/07/Hariprasad-CV-7-2015.pdf ·...